A plain-English reference to the 317 medical, biological, and pharmacology terms used across Peptides Unleashed. Search or browse alphabetically. Every term here also powers the hover-and-tap definitions inside our articles.
A
- #Actin Regulation cell-bio
- Actin is one of the most abundant proteins inside every cell. It assembles into tiny fibers that act like an internal skeleton — letting cells crawl, divide, and form muscle contractions. Actin regulation is the network of signals that tells these fibers when to grow, shrink, or rearrange. Peptides like Thymosin Beta-4 work directly on actin: TB-4 binds free actin molecules and helps cells reorganize their scaffolding during wound healing, blood vessel formation, and tissue repair.
- #Active Cancer pharma
- Active cancer refers to a current malignancy not yet treated to remission. Many peptides Casey covers — growth-hormone secretagogues, IGF-1-raising peptides, angiogenic peptides like BPC-157 and TB-500 — promote cell proliferation, angiogenesis, or both. Because tumors hijack these same pathways for growth, active cancer is a near-universal contraindication for these peptides. Cancer history is a relative contraindication that warrants oncology consultation before starting any growth-pathway peptide.
- #Adiponectin
- Adiponectin is a peptide hormone secreted by fat tissue. Despite being a 'fat hormone,' levels are typically lower in people with more visceral fat. High adiponectin is linked to better insulin sensitivity, lower inflammation, and protection against cardiovascular disease. Exercise, weight loss, and several metabolic peptides raise adiponectin.
- #Adrenal Gland endocrine
- The adrenal glands have two functional regions: the outer cortex makes cortisol, aldosterone (which controls salt and blood pressure), and small amounts of sex hormones; the inner medulla makes adrenaline (epinephrine) and noradrenaline (norepinephrine). The cortex receives its signal from pituitary ACTH; the medulla receives direct nerve input from the sympathetic nervous system. Chronic stress overworks the cortex; Casey's content links chronic-stress symptoms to adrenal physiology when discussing peptides studied for stress modulation.
- #Adverse Effect pharma
- An adverse effect (or adverse event in trial reporting) is any undesired, harmful, or unintended outcome associated with a drug, peptide, or other intervention. Adverse effects are graded by severity (mild/moderate/severe), expectedness (known versus unexpected), and seriousness (resulting in hospitalization, death, or major intervention). Common peptide adverse effects include injection site reactions, GI upset, transient fatigue, headache, and water retention. Serious adverse effects are rare in the peptides Casey covers, but long-term safety data remains limited for many.
- #Agonist pharmacology
- An agonist is a compound that binds a receptor and activates it, producing the same kind of response the body's natural signal would. GLP-1 receptor agonists like Semaglutide and Tirzepatide mimic the body's GLP-1 hormone. 'Full' agonists fully activate the receptor; 'partial' agonists activate it less than the natural signal. The agonist concept is the foundation of most peptide therapies.
- #Albuminuria renal
- Albuminuria is the presence of albumin (a protein) in urine, signaling damage to the glomerular filter. It's one of the earliest signs of kidney damage in diabetes and hypertension. Levels are typically reported as the urine albumin-to-creatinine ratio (UACR). It's a key endpoint in trials of kidney-protective therapies, including several GLP-1 receptor agonists.
- #All-Cause Mortality methodology
- All-cause mortality counts every death in a trial regardless of cause, making it the most unbiased survival endpoint (cause-of-death adjudication can be subjective). Trials that show all-cause mortality reduction are particularly persuasive. Several GLP-1 receptor agonists have reduced all-cause mortality in cardiovascular outcomes trials in type 2 diabetes.
- #Alopecia skin-disease-mention
- Alopecia is the medical term for hair loss. Androgenetic alopecia (pattern baldness) is the most common, driven by genetics and dihydrotestosterone. Alopecia areata is autoimmune patchy loss. Telogen effluvium is diffuse shedding after stress or illness. Peptides being explored for hair loss include GHK-Cu (mild effect, multifactorial), PTD-DBM, and Wnt-pathway modulators.
- #Alzheimer's neural-disease-mention
- Alzheimer's disease is a neurodegenerative disease causing progressive memory loss, cognitive decline, and ultimately loss of independence. It's marked pathologically by amyloid-beta plaques and tau tangles in the brain. Newer anti-amyloid antibodies (lecanemab, donanemab) modestly slow progression. Lifestyle factors (exercise, sleep, social engagement, blood pressure control) and many peptide-based neuroprotective strategies are under investigation.
- #Amino Acid molecular
- Amino acids are small molecules containing an amine group, a carboxyl group, and a side chain that defines their identity. The 20 standard amino acids link via peptide bonds in genetically specified orders to form proteins and peptides. Nine are 'essential' in humans (must come from diet); the rest can be synthesized. Peptide drug design takes advantage of natural amino acids and sometimes incorporates non-natural ones (e.g., D-amino acids, methylated residues) to resist enzymatic degradation, as in Semaglutide.
- #AMPK Activation cell-bio
- AMPK (AMP-activated protein kinase) is the master energy switch inside every cell. When ATP (cellular energy) drops, AMPK turns on and triggers fat burning, glucose uptake, mitochondrial growth, and cellular cleanup (autophagy). Exercise, fasting, and metformin all activate AMPK naturally. Many longevity and metabolic peptides — including MOTS-c, certain GLP-1s, and SLU-PP-332 — work by switching on AMPK, which is why they often produce effects similar to caloric restriction or exercise.
- #Amylin
- Amylin is a peptide co-secreted with insulin from pancreatic beta cells. It slows gastric emptying, suppresses glucagon, and promotes satiety — complementing insulin's effects. Cagrilintide is a long-acting amylin analog; CagriSema (cagrilintide + semaglutide) combines amylin and GLP-1 activation for stronger weight loss than either alone.
- #Amyloid neural
- Amyloid plaques are extracellular clumps of misfolded amyloid-beta protein found in the brains of people with Alzheimer's disease. Whether they cause Alzheimer's or are a byproduct of an earlier process is still debated. Anti-amyloid antibodies (lecanemab, donanemab) modestly slow Alzheimer's progression. Research into preventing or clearing amyloid buildup is ongoing, including with peptide-based approaches.
- #Anabolic
- Anabolic refers to metabolic processes that build complex molecules and tissues from simpler precursors, typically requiring energy input. Anabolic hormones include insulin, testosterone, growth hormone, and IGF-1. The term is often associated with anabolic steroids, but several peptides modulate anabolic signaling pathways — growth-hormone secretagogues (Sermorelin, Ipamorelin, Tesamorelin) increase IGF-1-mediated anabolism, and BPC-157 supports tissue-building processes during repair. Anabolic peptides are usually not as potent as anabolic-androgenic steroids.
- #Anabolic Steroid endocrine
- Anabolic steroids are synthetic derivatives of testosterone designed to enhance muscle protein synthesis and lean mass. They include testosterone esters (cypionate, enanthate), nandrolone, oxandrolone, and many others. They're Schedule III controlled substances in the US and require prescription. Casey's content draws a sharp line between peptides and anabolic steroids: most peptides do not bind androgen receptors and produce smaller, more nuanced effects with different side-effect profiles. Some users combine them, which compounds risk.
- #Androgen Receptor endocrine
- The androgen receptor (AR) is a nuclear receptor that binds testosterone and dihydrotestosterone (DHT). Once activated, AR moves into the cell nucleus and turns on genes that drive protein synthesis in muscle, bone growth, sebaceous gland activity, and male sexual development. Peptides themselves don't bind AR, but several peptide protocols restore upstream signaling — Kisspeptin-10, Gonadorelin, and HCG raise endogenous testosterone, which then activates AR. Selective androgen receptor modulators (SARMs) are a separate non-peptide class that activate AR directly in some tissues but not others.
- #Angiogenesis cell-bio
- Angiogenesis is the formation of new blood vessels from existing ones. It happens during wound healing, exercise-induced muscle growth, menstrual cycles, and unfortunately also tumor growth. Peptides like BPC-157, TB-500, and GHK-Cu are studied for their ability to accelerate angiogenesis in injured tissue, which is why they're researched for joint, tendon, and muscle recovery. VEGF (vascular endothelial growth factor) is the main signal that drives this process.
- #Angiogenic cardiovascular
- Angiogenic refers to substances or processes that promote angiogenesis — the growth of new blood vessels from existing vasculature. Key angiogenic growth factors include VEGF, FGF-2, and PDGF; angiogenic peptides include BPC-157 (via VEGF and nitric oxide upregulation), TB-500, and GHK-Cu. Adequate angiogenesis is essential for wound healing, tissue repair, and exercise adaptation, but excess angiogenesis is also a feature of tumor growth and diabetic retinopathy. This dual role is one reason peptide protocols caution against use with active cancer.
- #Animal Model research
- An animal model is a non-human species used to study biological processes or test medical interventions before human application. Rats and mice dominate peptide research because of cost, genetic tractability, and accumulated reference data. Common models include the gastric ulcer model (BPC-157), the diabetic db/db mouse (GLP-1 agonists), and the Achilles tendon transection model (TB-500). Animal results translate imperfectly to humans, so positive animal data establishes biological plausibility but doesn't guarantee human efficacy.
- #Antagonist pharmacology
- An antagonist binds a receptor and prevents the normal activator (agonist) from binding, with no signal of its own. Antagonists are useful when you want to block a process — antihistamines block histamine receptors, beta blockers block adrenergic receptors. In peptide research, antagonists help isolate which receptor a peptide is acting through.
- #Anti-Inflammatory immune
- Anti-inflammatory describes any agent that reduces inflammation. Mechanisms vary: NSAIDs block prostaglandins, steroids suppress immune cells broadly, biologics block specific cytokines, and many peptides (BPC-157, KPV, MOTS-c) shift the immune balance toward resolution. Diet patterns (Mediterranean, anti-inflammatory) and behaviors (sleep, exercise) also reduce chronic inflammation systemically.
- #Antioxidant cell-bio
- Antioxidants are compounds that donate electrons to stabilize free radicals, preventing them from harming DNA, proteins, and cell membranes. Your body makes its own (glutathione, superoxide dismutase, catalase) and gets others from food (vitamin C, vitamin E, polyphenols). Peptides like Glutathione (the body's master antioxidant) and GHK-Cu function as antioxidants directly. The Nrf2 pathway is the master switch that ramps up the body's own antioxidant production.
- #Anxiety neural-disease-mention
- Anxiety disorders are characterized by excessive, persistent fear or worry. They include generalized anxiety, panic disorder, social anxiety, and others. Mechanisms involve GABA, serotonin, the amygdala, and HPA-axis stress responses. Treatments include CBT, SSRIs, and short-term benzodiazepines. Selank is a Russian-developed peptide with anxiolytic effects, studied largely outside the US, primarily acting through GABAergic and tuftsin-like mechanisms.
- #Apoptosis cell-bio
- Apoptosis is the controlled self-destruction of cells, also called programmed cell death. It's how your body removes precancerous cells, sculpts tissue during development, and prunes immune cells after an infection. Too little apoptosis allows tumors to grow; too much causes tissue loss (as in heart attacks and neurodegeneration). Many peptides are studied for their anti-apoptotic effects in injured tissue — BPC-157 and Thymosin Beta-4, for example, protect heart and brain cells from premature death after injury.
- #Appetite Suppression
- Appetite suppression refers to a measurable reduction in food intake driven by changes in homeostatic and hedonic hunger signaling. GLP-1 receptor agonists slow gastric emptying and act centrally on hypothalamic appetite circuits to reduce hunger and food reward. Tirzepatide and Retatrutide add GIP and glucagon receptor effects that further increase satiety. The downside is that the same suppression can produce nausea, early satiety, and reduced protein intake, which is why dose titration and high-protein eating are emphasized on these protocols.
- #Atherosclerosis cardiovascular-disease-mention
- Atherosclerosis is the gradual deposition of cholesterol, immune cells, and scar tissue inside the walls of arteries. Plaques can narrow vessels and, if they rupture, trigger clots that cause heart attacks or strokes. Drivers include LDL cholesterol, hypertension, smoking, diabetes, and inflammation. Several peptides (GLP-1s, especially) reduce cardiovascular events in part by stabilizing or slowing plaque progression.
- #ATP (Adenosine Triphosphate) molecular
- Adenosine triphosphate (ATP) is the primary energy-carrying molecule in cells, releasing energy when its terminal phosphate bond is hydrolyzed to ADP. Cells continuously regenerate ATP via glycolysis (cytoplasm), the Krebs cycle, and oxidative phosphorylation (mitochondria). A typical human turns over about their body weight in ATP per day. Mitochondrial dysfunction shows up clinically as chronic fatigue, exercise intolerance, and neurological symptoms — and is a target for peptides like MOTS-c and SS-31.
- #Autoimmune immune-disease-mention
- Autoimmune diseases occur when the immune system loses tolerance to self-tissues and attacks them. There are over 80 known autoimmune diseases — rheumatoid arthritis (joints), lupus (multi-organ), MS (nervous system), Hashimoto's (thyroid), IBD (gut), psoriasis (skin), type 1 diabetes (pancreatic beta cells). Treatment usually means suppressing immune activity. Some peptides (KPV, Thymosin Alpha-1) are studied for immune modulation in autoimmunity.
- #Autophagy cell-bio
- Autophagy (literally 'self-eating') is the process cells use to break down and recycle their own components. It removes damaged proteins, old organelles, and even invading microbes. Fasting, exercise, and AMPK activation all turn on autophagy. Reduced autophagy is a hallmark of aging and is linked to Alzheimer's, Parkinson's, and metabolic disease. Many longevity peptides work by boosting autophagy.
B
- #Bacteriostatic Water pharma
- Bacteriostatic water is sterile water that contains 0.9% benzyl alcohol, an additive that prevents bacterial growth in a multi-dose vial. It's the standard diluent for reconstituting lyophilized peptides because once a vial is opened, the preservative lets the solution stay safe for injection for up to 28 days refrigerated. Plain sterile water can also be used but only for a single use because it has no antimicrobial protection. Casey's articles note that consumers sometimes confuse the two — using plain sterile water for a multi-day protocol risks contamination.
- #BDNF neural
- BDNF (brain-derived neurotrophic factor) is a protein that supports the survival, growth, and connection of neurons. It's central to learning, memory, and mood. Low BDNF is linked to depression, Alzheimer's, and cognitive decline. Exercise, quality sleep, intermittent fasting, and certain peptides (Semax, Selank, Cerebrolysin) are studied for their BDNF-raising effects.
- #Bioavailability pharmacology
- Bioavailability measures how much of a dose actually makes it into systemic circulation in active form. Intravenous dosing is 100% by definition; oral dosing is usually much lower because the gut and liver break down or filter much of the dose. Most peptides have near-zero oral bioavailability — gut enzymes destroy them. That's why most peptides are injected, and why companies engineer special delivery systems for oral versions (like oral Semaglutide).
- #Biological Age longevity
- Biological age estimates how 'old' your body actually is based on measurable biomarkers, in contrast to chronological age (birth date). Methods include epigenetic clocks (Horvath, GrimAge, PhenoAge), telomere length, and composite lab panels. A 50-year-old with a biological age of 42 has lower risk of age-related disease than a 50-year-old with a biological age of 58.
- #Biomarker methodology
- A biomarker is any objectively measured indicator of a biological process, disease state, or response to therapy. Examples include LDL cholesterol (cardiovascular risk), HbA1c (long-term glycemic control), and BDNF (neural health). Biomarkers let researchers track effects early, before clinical events (heart attacks, deaths) accumulate. The FDA recognizes some as 'surrogate endpoints' for approval.
- #Blood Pressure cardiovascular
- Blood pressure is measured as systolic (top number, force during a heartbeat) over diastolic (bottom number, force between beats). Normal is under 120/80. Chronic high blood pressure (hypertension) is one of the strongest modifiable risk factors for heart attack, stroke, kidney failure, and dementia. GLP-1 receptor agonists modestly lower blood pressure, contributing to their cardiovascular benefit.
- #Blood-Brain Barrier neural
- The blood-brain barrier (BBB) is formed by tightly joined endothelial cells in brain capillaries that block most molecules from leaving the blood and entering brain tissue. It protects neurons from toxins and pathogens, but is a major obstacle to drug delivery. Some peptides (Semax, Selank) cross intact; others require nasal delivery or special carriers to reach the central nervous system.
- #Body Composition
- Body composition refers to how much of your weight is fat versus lean tissue (muscle, bone, water). Two people of the same weight and height can have very different health profiles based on composition. Methods to measure include DXA, bioimpedance, and skinfold calipers. Modern weight-loss peptides are being evaluated not just for total weight lost but for how much lean mass is preserved.
- #Body Mass Index
- BMI = weight (kg) / height (m)². Under 18.5 is underweight, 18.5–24.9 normal, 25–29.9 overweight, 30+ obesity. It's quick and free but can't distinguish muscle from fat — a strong athlete and a sedentary person can have the same BMI with totally different health profiles. Most trials still use BMI for eligibility because it's universally available, but pair it with body composition or waist measurements for real insight.
- #Body Protection Compound (BPC) regenerative
- Body Protection Compound (BPC) refers to a larger 'organoprotective' protein originally isolated from human gastric juice that exhibited unusually broad cytoprotective and healing effects in early gastrointestinal research. BPC-157 is a 15-amino-acid fragment of this parent compound, designed to be stable in gastric juice (resistant to acid and enzymes) and orally as well as injectably active in animal models. The '157' refers to the position-numbered portion of the parent sequence. This nomenclature explains why some sources write 'BPC 157' and others 'PL-10,' an earlier research designation.
- #Bone Density tissue
- Bone density (bone mineral density, BMD) is the amount of mineral matter per square centimeter of bone, measured by dual-energy X-ray absorptiometry (DEXA). It peaks around age 30 and declines thereafter, with accelerated loss in postmenopausal women and older men. Low BMD defines osteopenia and osteoporosis and predicts fracture risk. Growth hormone, sex hormones, and adequate vitamin D, calcium, and weight-bearing exercise are the main determinants. Some peptide protocols (Sermorelin, Tesamorelin, MK-677) support BMD indirectly through GH/IGF-1, but specific osteoporosis peptides are a separate class.
- #Brain Fog neural
- Brain fog is a non-clinical term for subjectively impaired cognitive clarity, including reduced concentration, slow thinking, mild memory lapses, and a sense of mental sluggishness. Common drivers include poor sleep, chronic stress, post-viral fatigue (including long COVID), inflammation, hormonal imbalance, and dehydration. It overlaps with the cognitive symptoms of mild depression and hypothyroidism. Peptides marketed for cognitive support sometimes target brain fog secondarily by improving sleep (DSIP), modulating stress (Selank), or reducing inflammation (BPC-157).
C
- #C-Reactive Protein immune
- C-reactive protein (CRP) is made by the liver in response to inflammatory signals (especially IL-6). High-sensitivity CRP (hsCRP) is used to assess cardiovascular risk: under 1 mg/L is low, over 3 mg/L is high. CRP drops with weight loss, exercise, and several peptide therapies. It's a popular secondary endpoint because it's cheap and broadly responsive to inflammation reduction.
- #Cachexia musculoskeletal-disease-mention
- Cachexia is a wasting syndrome with severe muscle and fat loss, low appetite, inflammation, and weakness, occurring in chronic illness (especially cancer, heart failure, COPD, AIDS). Unlike starvation, cachexia doesn't reverse just by eating more — it's driven by inflammatory cytokines and metabolic dysregulation. It's a major cause of mortality in late-stage disease. Anabolic peptides and anti-inflammatory approaches are studied for cachexia, though no single therapy yet works well.
- #Cardiomyocyte cardiovascular
- Cardiomyocytes are the contractile cells of the heart. They're packed with mitochondria (about 30% of their volume) because pumping never stops. Unlike skeletal muscle, adult cardiomyocytes regenerate very slowly, which is why heart attacks leave permanent scars. Peptide research targets cardiomyocyte protection (preventing death after ischemia) and possibly regeneration via epicardial progenitor activation.
- #Cardiovascular Event cardiovascular
- Cardiovascular events are clinical endpoints used in trials — MACE ('major adverse cardiovascular events') typically counts cardiovascular death, non-fatal MI, and non-fatal stroke. These hard outcomes are what regulators care about most. Several GLP-1 receptor agonists (Semaglutide, Liraglutide, Dulaglutide) have demonstrated reduction in MACE in dedicated cardiovascular outcomes trials.
- #Cardiovascular Mortality methodology
- Cardiovascular mortality counts deaths attributed to cardiovascular causes (heart attack, stroke, heart failure, sudden cardiac death). It's a more targeted but more subjective endpoint than all-cause mortality, because some deaths require expert adjudication. It's a key component of MACE composite endpoints in cardiovascular trials.
- #Cartilage musculoskeletal
- Cartilage is a flexible, low-friction tissue that covers bone ends in joints and forms structures like the nose and ear. Joint cartilage (articular cartilage) has no blood supply or nerves and almost no ability to regenerate. Its wear and breakdown is the core problem in osteoarthritis. Peptides and small molecules promoting chondrocyte (cartilage cell) health are an active research area.
- #Cell Migration cell-bio
- Cell migration is the directed movement of cells across or through tissues, driven by reorganization of the actin cytoskeleton and chemical gradients (chemotaxis). Fibroblast migration into a wound site enables collagen deposition; endothelial cell migration is required for angiogenesis; immune cell migration mounts the inflammatory response. Thymosin Beta-4 directly regulates G-actin and is central to migration, which is part of its role in wound and cardiac repair. BPC-157 also enhances fibroblast and endothelial cell migration in preclinical assays.
- #Cell Proliferation cell-bio
- Cell proliferation is the increase in cell number through the cell cycle (G1, S, G2, M phases) producing two daughter cells from one parent. It's tightly regulated by growth factors, cyclins, and tumor suppressors; uncontrolled proliferation is a hallmark of cancer. Peptide growth factors (EGF, FGF, VEGF, IGF-1) stimulate proliferation in specific cell types, which underpins their roles in wound healing and tissue regeneration. Concern about excess proliferation is one reason peptide protocols caution against use in active cancer.
- #Cellular Signaling molecular
- Cellular signaling is the network of biochemical communications that allow cells to sense and respond to their environment. Signals begin with ligand-receptor binding (peptide hormones, growth factors, neurotransmitters), proceed through second messengers (cAMP, calcium, IP3), and end with changes in gene expression, enzyme activity, or cytoskeletal arrangement. Most peptide therapeutics work by binding specific receptors and triggering downstream signaling cascades. Casey's articles frequently invoke this concept because misunderstanding it leads consumers to expect 'direct' effects when the real action is several steps downstream.
- #Central Nervous System (CNS) neural
- The central nervous system (CNS) consists of the brain and spinal cord, contrasted with the peripheral nervous system (nerves outside the brain and spinal cord). The CNS integrates sensory input, processes it, and directs motor output, autonomic regulation, and cognition. It's protected by the blood-brain barrier, which restricts which peptides can reach it after peripheral administration. Intranasal peptides (Selank, Semax) and small lipid-soluble compounds cross more readily, which is partly why those peptides use that route.
- #Certificate of Analysis (COA) research
- A certificate of analysis (COA) is a quality-control document issued by a manufacturer or independent laboratory documenting the test results for a specific product lot. For peptides, a useful COA includes identity confirmation by mass spectrometry, purity by HPLC (typically ≥98% for research grade), and endotoxin levels for any peptide intended for injection. The COA should be lot-specific and dated. Casey's vendor reviews check whether COAs are public, recent, lot-matched, and performed by a credible independent lab.
- #Chemokine immune
- Chemokines are a subfamily of small cytokines whose main job is to attract immune cells (chemotaxis) to where they're needed — wounds, infections, tumors. They form concentration gradients that immune cells follow. Many inflammatory and autoimmune diseases involve excess chemokine signaling, and several drugs target chemokine receptors.
- #Chronic Inflammation immune
- Chronic inflammation is a persistent, low-grade activation of the immune system that, unlike acute inflammation, fails to resolve. It's driven by elevated pro-inflammatory cytokines (TNF-α, IL-6, IL-1β), high CRP, and macrophage infiltration into tissues. It underlies cardiovascular disease, type 2 diabetes, neurodegeneration, sarcopenia, and many cancers, and the related term 'inflammaging' captures the role this plays in biological aging. Multiple peptides — BPC-157, Thymosin Alpha-1, KPV, LL-37, Larazotide Acetate, GHK-Cu — are studied for their ability to dampen chronic inflammatory signaling.
- #Chronic Kidney Disease renal-disease-mention
- Chronic kidney disease (CKD) is long-standing reduced kidney function, usually defined by eGFR <60 mL/min/1.73m² for 3+ months or evidence of damage like albuminuria. Most common causes: diabetes and hypertension. Patients face higher risk of heart disease, anemia, bone disease, and eventually need for dialysis or transplant. GLP-1 receptor agonists are increasingly recognized for slowing CKD progression.
- #Circadian Rhythm neural
- The circadian rhythm is the internal ~24-hour cycle that governs sleep-wake patterns, hormone release (cortisol, growth hormone, melatonin), body temperature, and metabolism. It's set by light exposure to the eyes (via the suprachiasmatic nucleus in the hypothalamus) and reinforced by meal timing and activity. Misalignment (shift work, jet lag, blue light at night) is linked to many chronic diseases.
- #CKD renal-disease-mention
- CKD is short for chronic kidney disease and is the standard way the diagnosis appears in lab reports, charts, and trials. It's staged 1–5 by eGFR; albuminuria modifies the stage. Cardiovascular events are the most common complication and cause of death before reaching end-stage kidney failure. Several peptide therapies are in renal-protective trials.
- #Clearance pharmacology
- Clearance is the rate at which a drug is removed from the body, primarily by the kidneys and liver. It's a key driver of dosing frequency — high clearance means short duration, low clearance means longer duration. Kidney or liver impairment can drop clearance and cause drug accumulation, which is why dose adjustments are common in patients with these conditions.
- #Clinical Trial research
- A clinical trial is a prospective, controlled research study in human participants designed to evaluate the safety and efficacy of a medical intervention. Trials are organized into Phase 1 (safety, healthy volunteers), Phase 2 (efficacy and dosing, target population), Phase 3 (large-scale comparison to standard of care), and Phase 4 (post-marketing surveillance). Trial design features — randomization, blinding, placebo controls, registered endpoints — distinguish credible from low-quality evidence. Casey's content distinguishes between peptides with substantial trial data (Semaglutide, Tesamorelin) and those with mostly preclinical evidence (BPC-157, TB-500).
- #Cognitive Function neural
- Cognitive function describes the brain's information-processing capabilities: attention, working memory, episodic memory, executive function, language, processing speed, and reasoning. Cognitive function declines with normal aging and more steeply in dementias. Peptides studied for cognitive support — Semax, Selank, Noopept, Dihexa, Cerebrolysin — target neurotransmitter modulation, BDNF expression, and neuroplasticity. Effect sizes vary, and rigorous human trials in healthy adults remain limited for most.
- #Collagen musculoskeletal
- Collagen is the main structural protein in connective tissue, making up about 30% of total body protein. There are over 25 collagen types; types I (skin, bone, tendon) and II (cartilage) are most relevant clinically. Fibroblasts make and maintain it. Wound healing, scar formation, skin aging, and joint health all hinge on collagen production and turnover. GHK-Cu, for example, both stimulates collagen and promotes its remodeling.
- #Collagen Production tissue
- Collagen production refers to the rate and quality of collagen being made and deposited in tissues, encompassing fibroblast activity, gene expression of COL1A1 and COL3A1, post-translational modification, and incorporation into the extracellular matrix. It varies by tissue, age, and signaling environment. Production is upregulated during wound healing and downregulated by glucocorticoids, age, and oxidative stress. Several peptide protocols target this process: GHK-Cu most directly, BPC-157 indirectly through fibroblast activation, and growth-hormone-axis peptides through IGF-1-mediated effects.
- #Collagen Synthesis tissue
- Collagen synthesis is the multi-step process by which fibroblasts (or chondrocytes, in cartilage) produce procollagen chains, modify them with vitamin-C-dependent hydroxylation, secrete them, and assemble them into mature triple-helical collagen fibers. Synthesis declines with age and is impaired by smoking, UV damage, high blood sugar, and protein deficiency. Peptides like GHK-Cu, BPC-157, and TB-500 have shown the ability to stimulate fibroblast collagen production in research settings. Adequate dietary protein, glycine, and vitamin C remain foundational because peptides act on rate-limiting steps rather than replacing substrates.
- #Complement System immune
- The complement system is a cascade of approximately 30 proteins in the blood that, when activated, amplifies innate immunity by directly killing microbes via the membrane attack complex, opsonizing pathogens for phagocytosis, and recruiting inflammatory cells. Three activation pathways — classical, alternative, and lectin — converge on C3 cleavage. Dysregulated complement contributes to autoimmune diseases like lupus and inflammatory eye disease. Peptide therapeutics that fine-tune complement (other than the niche drug Pegcetacoplan) are not yet common, but the system is referenced in research on inflammaging and immune balance.
- #Confidence Interval methodology
- A confidence interval (typically 95% CI) is the range within which the true effect likely lies, given the data. A weight loss result of '-15% (95% CI -17% to -13%)' means the data are consistent with a true effect somewhere between -13% and -17%. Narrower intervals = more precision. If a CI crosses zero (or 1.0 for ratios), the result usually isn't statistically significant.
- #Contraindication pharma
- A contraindication is a specific situation in which a drug, peptide, or procedure should not be used because the potential harm outweighs benefit. Absolute contraindications mean 'do not use under any circumstances'; relative contraindications require risk-benefit weighing. Common peptide contraindications include active cancer (most growth-promoting peptides), pregnancy or breastfeeding (most peptides, due to insufficient safety data), and certain endocrine disorders. Casey's articles flag contraindications in every dosage guide.
- #Copper Peptide regenerative
- Copper peptides are small peptides that chelate (bind) copper ions, with GHK-Cu (glycyl-L-histidyl-L-lysine bound to copper(II)) being the most studied. The peptide-copper complex is naturally present in plasma and saliva, where it supports wound healing, fibroblast activity, angiogenesis, antioxidant defense, and collagen and elastin synthesis. GHK-Cu's plasma concentration declines significantly with age, motivating its use as a topical or injected supplement. Skin care, hair regrowth, and tendon healing are the most-researched applications.
- #Coronary cardiovascular
- Coronary arteries are the small arteries on the surface of the heart that feed the heart muscle. Blockage of a coronary artery (by plaque rupture and clot) causes heart attacks; stable narrowing causes angina. 'Coronary heart disease' and 'coronary artery disease' are common names for atherosclerosis of these vessels. GLP-1 receptor agonists reduce major coronary events in patients with type 2 diabetes.
- #Cortisol endocrine
- Cortisol is a steroid hormone produced by the adrenal glands. It rises in the morning to wake you up, with stress, and in response to low blood sugar. Short bursts mobilize energy and dampen inflammation. Chronically elevated cortisol (from stress, sleep loss, or Cushing's disease) causes muscle loss, fat gain (especially visceral), insulin resistance, immune suppression, and mood changes.
- #Crohn's Disease immune-disease-mention
- Crohn's disease is one of two main inflammatory bowel diseases (the other is ulcerative colitis). It causes transmural inflammation that can occur anywhere in the GI tract, most commonly the ileum and colon. Symptoms include diarrhea, abdominal pain, weight loss, and fistulas. Treatments include immunomodulators, biologics (anti-TNF, anti-IL-23), and sometimes surgery. KPV and BPC-157 are studied for GI inflammation.
- #Cross-Sectional methodology
- A cross-sectional study measures variables in a population at a single point in time. It's useful for estimating prevalence and identifying correlations, but it can't establish whether one factor causes another (because cause has to come before effect, and a single snapshot can't show timing). NHANES is a famous repeated cross-sectional survey.
- #Crossover methodology
- In a crossover trial, each participant gets both interventions in sequence (e.g., drug then placebo, or vice versa) with a washout period between. Because each person is compared to themselves, less variability sneaks in, so you can detect smaller effects with fewer participants. It works only for conditions that don't permanently change between phases and that have shorter-acting interventions.
- #CRP immune
- CRP is the standard lab abbreviation for C-reactive protein. The 'high-sensitivity' version (hsCRP) is the form used for cardiovascular and metabolic risk assessment. Levels under 1 mg/L are reassuring; over 3 mg/L are concerning. CRP is widely tracked in peptide research as a secondary measure of anti-inflammatory effects.
- #Cycling pharma
- Cycling is the practice of dosing a peptide for a defined period (often 4–12 weeks) followed by an off-period of weeks to months. The rationale includes preventing receptor desensitization, allowing the body's natural axis to recover (especially for growth-hormone-releasing peptides and gonadotropin-related peptides), and limiting cumulative exposure where long-term safety data is limited. Specific cycling protocols vary by peptide and goal; Casey's dosage articles include cycle recommendations alongside doses.
- #Cytokine immune
- Cytokines are signaling proteins secreted by immune cells (and many others) that regulate immune responses, inflammation, and tissue repair. Major families include interleukins (IL-1, IL-6, IL-10, IL-17), interferons, TNF-α, and chemokines. Too few cytokines = weak immune response; too many = autoimmune disease or 'cytokine storm.' Many peptides exert their effects by shifting cytokine balance.
D
- #Deep Sleep neural
- Deep sleep, also called slow-wave sleep (SWS) or N3, is the deepest stage of non-REM sleep, characterized by high-amplitude slow brain waves on EEG. It's when most growth hormone is released, glymphatic clearance of brain waste products is most active, and memory consolidation occurs. Deep sleep declines with age and is disrupted by alcohol, stress, sleep apnea, and inconsistent schedules. Many peptide protocols dose growth-hormone-releasing peptides at bedtime to align with natural deep-sleep GH pulses.
- #Depression neural-disease-mention
- Major depressive disorder (MDD) is a common mood disorder with persistent low mood, anhedonia (loss of pleasure), sleep changes, appetite changes, fatigue, and sometimes suicidal thoughts. Mechanisms involve neurotransmitters (serotonin, dopamine, norepinephrine), neuroinflammation, BDNF, and HPA-axis dysregulation. Treatments include SSRIs, psychotherapy, lifestyle changes, and newer agents (ketamine, psilocybin in trials). Some peptides (Selank, Semax) are studied for mood support.
- #Diarrhea gi
- Diarrhea is the passage of three or more loose or watery stools per day or more frequent than is normal for the individual. With GLP-1 receptor agonists (Semaglutide, Liraglutide) and dual/triple agonists (Tirzepatide, Retatrutide), diarrhea is among the most common adverse effects, usually mild and concentrated in the early titration weeks. Dose escalation is the main mitigation strategy. Persistent or severe diarrhea, blood in stool, or signs of dehydration warrant stopping the peptide and seeking medical evaluation.
- #Differentiation cell-bio
- Cell differentiation is how unspecialized cells (stem cells and progenitors) acquire the specific structure and function of mature cell types. It's driven by gene expression changes in response to signals from neighbors and the environment. Differentiation is central to development, healing, and regenerative medicine. Many peptides are studied for their ability to either drive differentiation of stem cells into needed tissue or hold them in a more flexible state.
- #Dopamine neural
- Dopamine is a neurotransmitter produced in midbrain regions (substantia nigra, ventral tegmental area) that signals reward prediction, motivation, and movement initiation. Parkinson's disease is caused by loss of dopamine-producing neurons in the substantia nigra. Dopamine pathways are also central to addiction, ADHD, schizophrenia, and motivation. Some peptides (e.g., PT-141, certain neuropeptides) indirectly influence dopamine signaling.
- #Dosing Protocol pharma
- A dosing protocol is the complete specification of how a peptide is to be administered: dose per injection, frequency per day, time of day, route (subcutaneous, intranasal, etc.), site rotation, cycle length, and any concurrent peptides. Protocols are typically derived from clinical trials when they exist (Semaglutide, Tesamorelin) or from preclinical extrapolation and community experience when they don't (BPC-157, TB-500). Casey's dosage articles always document the source and limitations of each protocol.
- #Double-Blind methodology
- Double-blind means both participants and the researchers measuring outcomes are unaware of which group is receiving the active treatment versus control. This prevents expectations from influencing the results. Combined with randomization and placebo control, it produces the most reliable evidence for whether a treatment actually works.
E
- #eGFR renal
- eGFR (estimated glomerular filtration rate) is the calculated rate at which blood is filtered through the kidneys, derived from serum creatinine, age, sex, and (in older equations) race. Normal is ≥90 mL/min/1.73m². Values below 60 for over 3 months define CKD. eGFR is the headline kidney number in research, including peptide trials for diabetic and non-diabetic kidney disease.
- #Ejection Fraction cardiovascular
- Ejection fraction (EF) is the fraction of blood ejected from the left ventricle with each heartbeat, expressed as a percentage. Normal is 55–70%; under 40% indicates heart failure with reduced EF (HFrEF). It's measured by echocardiogram or MRI. Improving EF (or stabilizing it) is a common endpoint in cardiovascular trials, including some peptide studies.
- #Elastin skin
- Elastin is a protein in connective tissue that allows skin, lungs, blood vessels, and other tissues to stretch and recoil. Like collagen, it's made by fibroblasts. Production largely stops after puberty, so elastin damage accumulates over a lifetime. Sun exposure and smoking accelerate elastin breakdown, producing wrinkles, sagging, and stiffened arteries.
- #Elastin Production tissue
- Elastin production is the synthesis of tropoelastin precursors by fibroblasts (skin), smooth muscle cells (arteries), and chondrocytes (cartilage), followed by cross-linking via lysyl oxidase to form mature elastic fibers. Production is largely complete by adolescence; little new elastin is made in adult tissues, so existing fibers must last decades. Damage from UV, glycation, and inflammation produces solar elastosis (skin) and arterial stiffness. GHK-Cu is the most-studied peptide for skin elastin support; oral collagen peptides primarily affect collagen rather than elastin.
- #Endothelial cardiovascular
- Endothelial refers to the endothelium — the single layer of specialized cells lining the interior surface of blood vessels, lymphatic vessels, and the heart. Endothelial cells regulate vascular tone, blood clotting, immune cell trafficking, and angiogenesis. Endothelial dysfunction (impaired nitric oxide signaling) is an early step in atherosclerosis, hypertension, and diabetes. Several peptide therapies target endothelial function — BPC-157 enhances nitric oxide signaling, GHK-Cu supports endothelial migration, and GLP-1 agonists improve endothelial-mediated vasodilation.
- #Endothelial Cells cardiovascular
- Endothelial cells form a single-cell-thick layer on the inside of every blood vessel. They control what passes between blood and tissue, release nitric oxide to relax vessels, and regulate clotting and inflammation. 'Endothelial dysfunction' is one of the earliest signs of cardiovascular disease and diabetes. Several peptides are studied for their ability to protect or restore endothelial function, including BPC-157, MOTS-c, and Klotho.
- #Endothelial Dysfunction cardiovascular
- Endothelial dysfunction is when endothelial cells (the lining of blood vessels) lose their ability to relax vessels, manage clotting, and limit inflammation. It precedes visible atherosclerosis by years and is reversible in early stages. Causes include hypertension, smoking, diabetes, and aging. It's improved by exercise, diet changes, and several peptide therapies (notably those that boost nitric oxide or reduce oxidative stress).
- #Energy Expenditure
- Total daily energy expenditure (TDEE) is the sum of three components: resting metabolic rate (60–75%), the thermic effect of food (about 10%), and the energy cost of physical activity, including planned exercise and non-exercise activity thermogenesis (NEAT). Peptides that modestly raise growth hormone, lean mass, or mitochondrial activity can shift TDEE by a few hundred calories per day, but no peptide produces dramatic effortless weight loss. Realistic protocols always emphasize diet and training because peptides modify the slope of the response, not the underlying inputs.
- #Enzyme molecular
- An enzyme is a protein (or rarely an RNA — ribozyme) that catalyzes a specific biochemical reaction by lowering its activation energy. Enzymes are highly specific for their substrates and are regulated by inhibitors, activators, post-translational modification, and gene expression. Drug names ending in -ase usually refer to an enzyme target: kinases (phosphorylate proteins), proteases (cleave peptide bonds), reductases (transfer electrons). Some peptide therapies act as enzyme inhibitors; others, including most metabolic peptides, modulate enzyme activity indirectly through signaling.
- #Epicardial Progenitor Cells cardiovascular
- Epicardial progenitor cells are a population of stem cells found in the epicardium, the outer protective layer of the heart. During fetal development they differentiate into several heart cell types including coronary smooth muscle, fibroblasts, and even new cardiomyocytes. After birth they go mostly dormant, but researchers are exploring how to wake them up after a heart attack to regenerate damaged tissue. Several peptides — including Thymosin Beta-4 — are studied for their ability to reactivate these cells and improve heart repair.
- #Epigenetic molecular
- Epigenetics refers to changes in gene activity caused by chemical marks on DNA or the proteins around it — not by changes in the DNA sequence. Diet, exercise, stress, and aging all leave epigenetic marks. The 'epigenetic clock' is one of the most reliable measures of biological age. Many longevity and anti-aging interventions are evaluated by whether they reverse epigenetic age.
- #Epigenetic Clock longevity
- Epigenetic clocks measure biological age from DNA methylation patterns at specific sites. Horvath's clock (2013) and second-generation clocks like GrimAge and PhenoAge are among the strongest predictors of mortality and age-related disease. They're now used in some longevity trials as a primary outcome — though whether changing the clock reading actually slows aging is still being established.
- #Epithelial Cells cell-bio
- Epithelial cells cover surfaces — outer skin, gut lining, airway lining, and the surfaces of glands and organs. They form barriers that decide what gets in and out, and they constantly turn over (the gut lining replaces itself every few days). Peptides like KPV, BPC-157, and GHK-Cu are studied for their ability to repair damaged epithelium in the gut, skin, and other surfaces.
- #Estradiol endocrine
- Estradiol (E2) is the most potent estrogen, produced mainly in the ovaries during a woman's reproductive years and in smaller amounts in fat, adrenals, and testes. It supports menstrual cycles, pregnancy, bone density, cognitive function, cardiovascular health, and skin. Levels drop sharply at menopause. It influences many peptide pathways including kisspeptin-driven reproductive signaling.
- #Estrogen endocrine
- Estrogen is a family of steroid hormones that includes estradiol (the most potent), estrone, and estriol. In women it drives the menstrual cycle, breast development, and protects bone density. In men, a small amount made by the aromatase enzyme converting testosterone to estradiol is critical for libido, bone, and brain function. Peptide protocols that raise testosterone also raise estrogen via aromatization. Casey's articles flag this because excessive aromatization can cause water retention, mood changes, and gynecomastia in men, which sometimes prompts the use of aromatase inhibitors.
- #Exercise Mimetic pharmacology
- Exercise mimetics are molecules that activate the same cellular pathways exercise does — AMPK, PGC-1α, and mitochondrial biogenesis — to produce some of the same benefits (better metabolism, more endurance, fat oxidation) without physical activity. They are studied for people who can't exercise due to injury, illness, or disability. SLU-PP-332 and MOTS-c are two peptide candidates being investigated as exercise mimetics; they don't replace training, but they may amplify its effects.
- #Extracellular Matrix musculoskeletal
- The extracellular matrix (ECM) is the network of proteins (collagen, elastin, fibronectin) and sugars surrounding cells in tissues. It provides structure, transmits forces, and carries signals between cells. Damage to ECM (from injury, aging, or disease) underlies many conditions, from osteoarthritis to skin aging to fibrotic organ disease. Peptides that remodel ECM (GHK-Cu, BPC-157) are widely studied.
F
- #Fasting Glucose
- Fasting plasma glucose (FPG) measures blood glucose after a minimum 8-hour fast. Under 100 mg/dL is normal, 100–125 mg/dL is pre-diabetic, 126+ on two tests is diabetic. It's a cheaper, simpler alternative to HbA1c but reflects a single moment in time. Both are commonly tracked in metabolic peptide trials.
- #Fat Oxidation
- Fat oxidation is the metabolic burning of fatty acids inside mitochondria via beta-oxidation, producing acetyl-CoA that enters the Krebs cycle for ATP production. Fat oxidation increases during fasting, low-carbohydrate eating, and moderate-intensity aerobic exercise, and decreases when carbohydrate availability is high. Growth-hormone-based peptides, MOTS-c, and exercise-mimetic compounds all aim to increase fat oxidation. Some consumers conflate fat oxidation with weight loss — the two only align when calorie balance is also negative.
- #Fatty Liver
- Fatty liver (hepatic steatosis) is the build-up of triglycerides inside liver cells. It's the earliest and most common stage of metabolic liver disease. Causes include insulin resistance, obesity, excess fructose intake, and (in a separate category) heavy alcohol. Early-stage fatty liver is reversible with weight loss, exercise, and metabolic peptides; later stages (NASH, fibrosis, cirrhosis) are harder to reverse.
- #FGF21 longevity
- FGF21 is a hormone secreted mainly by the liver during fasting, ketogenic diets, and metabolic stress. It promotes fat burning, improves insulin sensitivity, increases adiponectin, and may extend lifespan in animals. FGF21 analogs (efruxifermin, pegozafermin) are in clinical trials for NASH and metabolic disease. It's also a myokine, released by exercising muscle.
- #Fibroblast cell-bio
- Fibroblasts produce collagen, elastin, and other matrix proteins that hold tissues together. They're the workhorses of wound healing — they fill in injuries with scar tissue and signal other cells to follow. Too few fibroblasts and wounds don't close; too many or too active and you get fibrosis (excessive scarring) in organs like liver, lungs, or heart. GHK-Cu and BPC-157 both modulate fibroblast activity during repair.
- #Fibroblast Activity tissue
- Fibroblast activity refers to the metabolic, secretory, and migratory output of fibroblasts — the workhorse cells of connective tissue that synthesize collagen, elastin, glycosaminoglycans, and other extracellular matrix components. Active fibroblasts proliferate at wound edges, migrate into healing tissue, and remodel scar tissue over months. Senescent fibroblasts (more common with age) lose this activity and secrete pro-inflammatory factors instead. GHK-Cu, BPC-157, and TB-500 are studied for their ability to stimulate fibroblast proliferation and collagen output.
- #Fibrosis musculoskeletal
- Fibrosis is the buildup of excess connective tissue (mostly collagen) in an organ in response to chronic injury or inflammation. Some scar formation is helpful for repair; too much replaces working tissue with stiff, non-functional scar. Liver fibrosis (from NASH or hepatitis) leads to cirrhosis; lung fibrosis (IPF) is often fatal. Anti-fibrotic peptides are an active research area.
- #Follicle-Stimulating Hormone (FSH) endocrine
- Follicle-stimulating hormone (FSH) is released from the anterior pituitary alongside LH in response to GnRH. In men, FSH acts on Sertoli cells in the testes to support spermatogenesis (sperm production); in women, it drives the growth of ovarian follicles during the first half of the menstrual cycle. Both LH and FSH are suppressed by exogenous testosterone, which is why men on testosterone replacement often need adjunctive peptides like HCG or Gonadorelin to maintain fertility. FSH lab values appear on hormone panels and help distinguish primary from secondary hypogonadism.
G
- #GABA neural
- GABA (gamma-aminobutyric acid) is the brain's principal inhibitory neurotransmitter. It dampens neuronal firing, producing calm, relaxation, and sleep. Many anxiety and sleep medications (benzodiazepines, zolpidem, alcohol) work by enhancing GABA signaling. Selank and other anxiolytic peptides modulate GABA-related circuits. Low GABA tone is associated with anxiety disorders and insomnia.
- #Gastric Emptying
- Gastric emptying is the rate at which the stomach passes its contents to the duodenum. Slower emptying produces a smaller, more gradual rise in blood glucose after meals and a longer-lasting feeling of fullness. GLP-1 receptor agonists slow gastric emptying significantly — a major mechanism behind both their glycemic effects and the GI side effects (nausea, fullness) people sometimes report.
- #Gastric Inhibitory Peptide (GIP)
- Gastric inhibitory peptide (GIP, also called glucose-dependent insulinotropic polypeptide) is a 42-amino-acid incretin hormone released by K cells in the duodenum and upper jejunum in response to food. Along with GLP-1, GIP increases glucose-stimulated insulin release from pancreatic beta cells. GIP also has effects on fat tissue and bone metabolism. Tirzepatide (Mounjaro, Zepbound) is the first approved dual GIP/GLP-1 receptor agonist; its weight-loss effect is greater than GLP-1 alone, suggesting GIP receptor activity meaningfully adds to the metabolic benefit.
- #Gastrointestinal gi
- The gastrointestinal (GI) tract is the digestive system — esophagus, stomach, small intestine, large intestine, and accessory organs (liver, pancreas, gallbladder). It's home to 70% of the immune system and the gut microbiome. Many peptides are studied for GI conditions (BPC-157 for ulcers and inflammation, KPV for IBD, teduglutide for short bowel syndrome).
- #Gene Expression molecular
- Gene expression is how the DNA blueprint becomes actual proteins and cellular functions. Every cell carries the full genome, but only expresses a subset of genes at any time, and the level of expression varies with signals from inside and outside the cell. Peptides influence gene expression by binding receptors that then turn on transcription factors — that's how a tiny molecule can produce big downstream effects.
- #Ghrelin
- Ghrelin is a peptide hormone made mainly in the stomach. Levels rise before meals and fall after eating. It activates appetite centers in the brain and also stimulates growth hormone release (its receptor is GHSR-1a). Growth hormone secretagogues like Ipamorelin and GHRP-2 are synthetic ghrelin mimetics — designed to trigger GH release without producing strong hunger.
- #GHRH endocrine
- GHRH is the abbreviation for growth hormone-releasing hormone, the upstream signal that triggers growth hormone release from the pituitary. GHRH analogs (Sermorelin, CJC-1295, Tesamorelin) are designed to work via the same receptor with longer duration than the natural hormone (which lasts only minutes). They produce more natural pulsatile GH release than direct GH injection.
- #Glomerular Filtration renal
- Glomerular filtration is the kidney's primary filtration process, occurring in millions of tiny tufts of capillaries (glomeruli). It removes waste while keeping cells and large proteins in the blood. The glomerular filtration rate (GFR) is the volume filtered per minute and is the main measure of kidney function. eGFR is the lab-calculated estimate used in routine care.
- #GLP-1
- GLP-1 is a peptide hormone released by gut cells after meals. It boosts insulin release, slows gastric emptying, and signals satiety to the brain. The natural hormone is destroyed in minutes, but engineered analogs (Semaglutide, Liraglutide) resist that breakdown and last hours to a week. GLP-1 receptor agonists are now the most-studied class of metabolic drugs and have transformed treatment of type 2 diabetes and obesity.
- #GLP-1 Receptor
- The glucagon-like peptide-1 (GLP-1) receptor is a G-protein-coupled receptor expressed on pancreatic beta cells, in the gut, and in several brain regions including the hypothalamus. Activation increases glucose-dependent insulin secretion, slows gastric emptying, reduces glucagon release, and produces satiety. GLP-1 receptor agonist drugs — Liraglutide, Semaglutide (Ozempic, Wegovy), and Dulaglutide — bind this receptor with a longer half-life than native GLP-1. Tirzepatide is a dual GLP-1/GIP agonist; Retatrutide is a triple GLP-1/GIP/glucagon agonist.
- #GLP-1 Receptor Agonist
- A GLP-1 receptor agonist is a compound that binds and activates the GLP-1 receptor, producing GLP-1's effects on insulin release, appetite, gastric emptying, and weight. The class includes Semaglutide, Liraglutide, Dulaglutide, and the dual/triple agonists Tirzepatide and Retatrutide. They're indicated for type 2 diabetes and obesity and are being studied for cardiovascular protection, kidney disease, MASH/NASH, and addiction.
- #Glucagon
- Glucagon is a 29-amino-acid peptide hormone secreted by alpha cells in the pancreatic islets when blood glucose falls. It acts mainly on the liver, where it triggers glycogenolysis (breakdown of stored glycogen to glucose) and gluconeogenesis (new glucose production from amino acids). Glucagon and insulin work in opposition to keep blood sugar in a narrow range. Some newer obesity peptides — including Tirzepatide and Retatrutide — act as dual or triple agonists that include the glucagon receptor, leveraging glucagon's metabolic-rate-boosting effect.
- #Glucagon-Like Peptide
- Glucagon-like peptides are products of the proglucagon gene. GLP-1 is the famous one — it regulates blood sugar and appetite. GLP-2 protects and grows the gut lining and is the basis of teduglutide, used for short bowel syndrome. The naming reflects their structural similarity to glucagon, even though their effects differ.
- #Glucose Metabolism
- Glucose metabolism encompasses the absorption of dietary carbohydrate into glucose, its uptake into cells via insulin and GLUT transporters, its use for ATP through glycolysis, and its storage as glycogen in liver and muscle. Dysregulation produces hyperglycemia (high blood sugar), insulin resistance, and type 2 diabetes. GLP-1, GIP, and dual/triple agonist peptides — Semaglutide, Tirzepatide, Retatrutide — improve glucose metabolism mainly by enhancing glucose-dependent insulin release and slowing gastric emptying.
- #Glutamate neural
- Glutamate is the most abundant excitatory neurotransmitter in the brain. It's essential for learning, memory, and most cognitive function, acting through NMDA and AMPA receptors. But excess glutamate causes 'excitotoxicity' — overstimulating neurons until they die. Excitotoxicity contributes to stroke damage, traumatic brain injury, and neurodegeneration. Some neuroprotective peptides act partly by reducing glutamate-driven damage.
- #Glycemic Control
- Glycemic control refers to the overall management of blood glucose levels, usually measured by HbA1c plus daily fingersticks or continuous glucose monitors (CGMs). Good control reduces risk of long-term complications (kidney, eye, nerve, cardiovascular). Modern tools — GLP-1s, dual agonists, CGM-guided insulin — have made tighter, safer control more achievable than a decade ago.
- #Gonadotropin-Releasing Hormone (GnRH) endocrine
- Gonadotropin-releasing hormone (GnRH), also called LHRH, is a 10-amino-acid peptide produced by the hypothalamus in pulses every 60–90 minutes. Each pulse triggers the pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn drive testosterone and sperm production in men and the menstrual cycle in women. Continuous (non-pulsatile) GnRH actually shuts the system down, which is how GnRH-agonist drugs treat hormone-driven cancers. Gonadorelin is a synthetic GnRH used to restore pulsatile signaling after suppression.
- #Growth Factor molecular
- Growth factors are small proteins that act on receptors to direct cell behavior. Examples include VEGF (drives new blood vessel growth), IGF-1 (drives muscle and bone growth), BDNF (supports neurons), and TGF-β (controls scarring). Many therapeutic peptides either are growth factors, mimic them, or stimulate their release.
- #Growth Hormone endocrine
- Growth hormone (GH, somatotropin) is a peptide hormone released in pulses by the pituitary, especially during deep sleep and exercise. In children it drives height; in adults it supports muscle protein synthesis, fat metabolism, and recovery via IGF-1. GH secretagogues (Ipamorelin, CJC-1295, Sermorelin, Tesamorelin) stimulate the body's own pulsatile GH release rather than supplying GH directly, preserving more physiologic patterns.
- #Growth Hormone Secretagogue endocrine
- A growth hormone secretagogue (GHS) is any molecule — peptide or small drug — that triggers the pituitary to release endogenous growth hormone. There are two main classes: GHRH analogs (Sermorelin, Tesamorelin, CJC-1295) bind the growth-hormone-releasing-hormone receptor, while ghrelin mimetics (Ipamorelin, GHRP-2, GHRP-6, MK-677/Ibutamoren) bind the ghrelin receptor in the pituitary. The advantage of secretagogues over injected HGH is that they preserve the natural pulsatile rhythm of GH release and don't fully shut down the feedback loop, lowering some long-term risks.
- #Growth Hormone-Releasing Hormone endocrine
- Growth hormone-releasing hormone (GHRH) is a 44-amino-acid peptide secreted by the hypothalamus. It binds the GHRH receptor on pituitary cells, triggering pulsatile release of growth hormone. Sermorelin and CJC-1295 are GHRH analogs designed to mimic this signal with longer half-lives. Tesamorelin is a GHRH analog approved for HIV-associated visceral fat loss.
- #Gut Health gi
- Gut health is an umbrella concept covering microbiome diversity, intestinal barrier integrity, absence of chronic inflammation, regular motility, and absence of symptoms like bloating, pain, or irregularity. The gut also houses much of the immune system and produces serotonin and other neuromodulators, linking gut function to immune and mental health. BPC-157 has substantial preclinical data for protecting and healing the GI tract; Larazotide Acetate is studied for restoring tight-junction integrity in leaky-gut conditions.
- #Gut Microbiome gi
- The gut microbiome is the community of microorganisms (mostly bacteria) inhabiting the GI tract — about as many cells as the rest of your body combined. It digests fiber, produces short-chain fatty acids and some vitamins, trains the immune system, and influences brain chemistry via the gut-brain axis. Diet is the strongest lever; some peptides also indirectly modulate microbiome composition.
H
- #Hair Follicle skin
- Hair follicles are tube-shaped structures in skin that produce hair. Each follicle cycles through growth, transition, and rest phases. Disturbances in cycling cause hair loss; the follicle's stem cells can also help regenerate nearby skin after injury. GHK-Cu, PTD-DBM, and other peptides are studied for hair growth via follicle stimulation, anti-inflammatory effects, and stem cell support.
- #Half-Life pharmacology
- Half-life is the time required for the concentration of a drug in the bloodstream to drop by 50%. A drug with a short half-life (hours) needs frequent dosing; one with a long half-life (days to weeks) can be given less often. Semaglutide's ~7-day half-life is why it's a once-weekly injection; older GLP-1s with shorter half-lives needed daily shots. Peptide engineering often focuses on extending half-life.
- #HbA1c
- HbA1c (hemoglobin A1c, or 'A1c') measures the percentage of hemoglobin in red blood cells with glucose stuck to it. Because red cells live about 3 months, HbA1c reflects average glucose over that span. Under 5.7% is normal, 5.7–6.4% is pre-diabetic, 6.5%+ is diabetic. GLP-1 receptor agonists typically lower HbA1c by 1.0–2.5 percentage points — a clinically major reduction.
- #Heart Failure cardiovascular-disease-mention
- Heart failure is a chronic syndrome where the heart muscle is too weak or stiff to pump enough blood. Causes include prior heart attacks, long-standing hypertension, valve disease, and diabetes. It's classified by ejection fraction: HFrEF (reduced) and HFpEF (preserved). GLP-1 receptor agonists like Semaglutide showed benefit in HFpEF trials, expanding the use case for these peptides beyond diabetes and weight loss.
- #Hippocampus neural
- The hippocampus is a curved brain structure in the temporal lobe critical for forming new long-term memories and spatial navigation. It's one of the few brain regions where neurogenesis continues in adulthood. Hippocampal shrinkage is an early sign of Alzheimer's, depression, and chronic stress. Peptides that boost BDNF and neurogenesis often act prominently here.
- #HOMA-IR
- HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is calculated as (fasting glucose × fasting insulin) / 405. Higher numbers indicate more insulin resistance; under ~1.0 is considered healthy. It's a quick, inexpensive proxy for insulin resistance using two routine lab values and is widely used in research and metabolic medicine.
- #Hormesis longevity
- Hormesis is a biological response in which low doses of a stressor produce beneficial adaptations, while higher doses are harmful. Exercise, intermittent fasting, sauna heat, cold exposure, and even some phytochemicals work hormetically. Many longevity interventions and exercise mimetics are essentially harnessing hormesis — turning on the cell's stress-defense programs without the underlying stress.
- #Hormonal Balance endocrine
- Hormonal balance is the colloquial term for healthy, coordinated function of the body's hormone-producing axes — the hypothalamic-pituitary-gonadal axis, hypothalamic-pituitary-adrenal axis, hypothalamic-pituitary-thyroid axis, and pancreatic insulin/glucagon signaling. Imbalance arises from chronic stress, aging, sleep deprivation, obesity, autoimmune thyroid disease, and exogenous hormone use. Many peptide protocols target restoring balance after suppression (Kisspeptin-10, Gonadorelin after suppression) or as gentle nudges back toward youthful patterns (growth-hormone secretagogues).
- #Hormonal Imbalance endocrine
- Hormonal imbalance is a non-specific clinical descriptor for hormone levels outside the optimal range for the individual, producing symptoms like fatigue, low libido, weight gain, mood instability, sleep disruption, irregular cycles, or hair changes. Common patterns include low testosterone, low estrogen/progesterone, elevated cortisol, hypothyroidism, or insulin resistance. Diagnosis requires lab testing, not just symptom matching. Peptide protocols generally support specific imbalances rather than functioning as broad-spectrum hormonal rebalancing.
- #HPLC (High-Performance Liquid Chromatography) research
- High-performance liquid chromatography (HPLC) is an analytical technique that separates components of a chemical mixture by pumping it through a column under high pressure; each component exits at a characteristic time based on its interaction with the column packing. For peptides, HPLC quantifies purity by comparing the peak area of the target peptide to total peak area in the chromatogram. Purity ≥98% by HPLC is the typical research-grade specification quoted on COAs. The technique can also confirm identity when paired with mass spectrometry detection (LC-MS).
- #HSDD endocrine-disease-mention
- Hypoactive sexual desire disorder (HSDD) is persistent or recurrent lack of sexual interest causing distress and not better explained by relationship issues or medications. It affects roughly 10% of women. PT-141 (Bremelanotide, brand name Vyleesi) is FDA-approved for premenopausal HSDD; it activates melanocortin receptors that influence sexual desire pathways. Cognitive-behavioral therapy and addressing contributing factors are also recommended.
- #Hyaluronic Acid skin
- Hyaluronic acid (hyaluronan) is a glycosaminoglycan that binds up to 1,000 times its weight in water. Found throughout the body (especially in skin, joints, and eyes), it gives tissues volume and lubrication. Skin levels drop with age, contributing to wrinkles and loss of plumpness. It's used in topical skincare, dermal fillers, joint injections, and eye drops.
- #Hyperglycemia
- Hyperglycemia is elevated blood glucose. Fasting levels over 100 mg/dL are 'pre-diabetic'; over 126 mg/dL are diabetic. Chronically high glucose damages blood vessels, nerves, kidneys, and eyes. GLP-1 receptor agonists are highly effective at lowering hyperglycemia without causing the opposite problem (hypoglycemia) in most patients, because they only boost insulin when glucose is elevated.
- #Hypertension cardiovascular-disease-mention
- Hypertension is sustained blood pressure ≥130/80 mmHg (current US guidelines). It's usually symptomless but accelerates damage to arteries, heart, kidneys, and brain. About half of US adults have it; only about a quarter have it well-controlled. Lifestyle (diet, exercise, weight loss) plus medications are the foundation; some peptides under study (notably GLP-1s and natriuretic peptide analogs) have modest blood-pressure-lowering effects.
- #Hypoglycemia
- Hypoglycemia is blood glucose under about 70 mg/dL. It's most often seen in people taking insulin or sulfonylureas; less common with GLP-1s or metformin because those don't push glucose lower than needed. Symptoms include shakiness, sweating, hunger, and confusion; severe lows can cause seizures or unconsciousness. Treatment is fast-absorbing carbs (juice, glucose tabs).
- #Hypogonadism endocrine-disease-mention
- Hypogonadism is the failure of the gonads (testes or ovaries) to produce normal levels of sex hormones. In men it presents as low testosterone, low libido, fatigue, muscle loss, and mood changes; in women as menstrual irregularity, low estrogen, and infertility. Primary hypogonadism is gonadal failure; secondary is pituitary/hypothalamic. Kisspeptin-10 and Enclomiphene are studied for upstream stimulation; testosterone or estrogen replacement is the conventional treatment.
- #Hypothalamus neural
- The hypothalamus sits above the pituitary and produces 'releasing' and 'inhibiting' hormones that travel a short distance into the pituitary to switch downstream hormones on or off. Key examples include GHRH (turns on growth hormone), GnRH (turns on LH and FSH), CRH (turns on cortisol), and TRH (turns on thyroid hormone). The hypothalamus also senses temperature, hunger, thirst, and circadian cues, integrating them into hormonal output. Peptides like Kisspeptin-10 and Gonadorelin act directly at hypothalamic-pituitary signaling steps.
I
- #IBD immune-disease-mention
- IBD (inflammatory bowel disease) refers to chronic immune-mediated inflammation of the GI tract — primarily Crohn's disease and ulcerative colitis. Symptoms include diarrhea, abdominal pain, bleeding, weight loss, and extra-intestinal manifestations (joints, skin, eyes). Treatments include 5-ASAs, immunomodulators, biologics, and JAK inhibitors. KPV and BPC-157 are studied for gut inflammation, mainly in preclinical work.
- #IGF-1 molecular
- IGF-1 is a peptide hormone produced mainly by the liver in response to growth hormone. It travels in the blood and tells muscle, bone, and other tissues to grow and divide. IGF-1 is the workhorse behind most of growth hormone's anabolic effects. Growth hormone secretagogue peptides (Ipamorelin, CJC-1295, Sermorelin) raise IGF-1 indirectly by stimulating natural GH release. Higher IGF-1 helps with muscle and recovery; chronically very high IGF-1 may accelerate aging.
- #Immune Modulation immune
- Immune modulation refers to interventions that adjust immune activity toward a healthier set point rather than universally suppressing or stimulating it. Modulators can dampen overactive immunity in autoimmune disease, restore balanced T-cell function in chronic infection, or sharpen response in immune senescence. Thymosin Alpha-1 is the canonical immunomodulatory peptide; LL-37, Thymulin, and KPV are also studied for context-dependent effects. The distinction from immunosuppression is important — modulation aims for balance, not blanket suppression.
- #Immune Response immune
- The immune response is the coordinated activity of innate (rapid, non-specific) and adaptive (slower, targeted, with memory) immune systems against pathogens, abnormal cells, or tissue damage. Innate response includes barrier defenses, macrophages, and neutrophils; adaptive response is led by T-cells and antibody-producing B-cells. Aging blunts adaptive response — a phenomenon called immune senescence — while chronic inflammation rises (inflammaging). Several peptides are studied for restoring components of an aging immune response.
- #In Vitro methodology
- In vitro studies are done in controlled environments outside a living organism — typically cells in culture, isolated tissues, or biochemical assays. They're ideal for studying molecular mechanisms but conditions are simplified compared to a real body. A peptide that works in vitro may not work in vivo because of pharmacokinetics, tissue distribution, or compensatory biology.
- #In Vivo methodology
- In vivo means within a living organism. In vivo studies preserve the complexity of a real body — circulation, metabolism, immune system, organ interactions — that in vitro studies miss. Animal in vivo (mice, rats, pigs) is usually the bridge between cell studies and human trials. Human in vivo studies are clinical trials.
- #Incretin
- Incretins are hormones released by the gut after eating that amplify the insulin response to incoming glucose. The two main incretins are GLP-1 and GIP. The 'incretin effect' means oral glucose triggers about twice the insulin response of an equal IV dose — a built-in safeguard against post-meal blood sugar spikes. Tirzepatide and Retatrutide deliberately activate both incretin receptors for stronger metabolic effects.
- #Inflammaging longevity
- Inflammaging is the chronic, sterile, low-grade inflammation that develops with age. Drivers include senescent cells (SASP), gut barrier breakdown, mitochondrial dysfunction, and accumulated cellular damage. It's increasingly seen as a common upstream cause of cardiovascular disease, dementia, cancer, sarcopenia, and metabolic disease. Anti-inflammatory peptides and senolytics are being studied to reduce it.
- #Inflammation immune
- Inflammation is the immune system's response to harm — infection, injury, or irritants. Acute inflammation (redness, heat, swelling, pain) is essential for healing. Chronic, low-grade inflammation drives nearly every age-related disease — heart disease, diabetes, cancer, dementia. Many peptides have anti-inflammatory effects (BPC-157, KPV, Thymosin Alpha-1) and CRP is the most common lab marker.
- #Inflammatory Cytokine immune
- Inflammatory cytokines are small proteins secreted mainly by macrophages, T-cells, and other immune cells that coordinate the immune response. Classic pro-inflammatory cytokines include TNF-α, IL-1β, IL-6, and IL-17; anti-inflammatory cytokines include IL-10 and TGF-β. Elevated pro-inflammatory cytokines are biomarkers of chronic inflammatory disease and inflammaging. Peptides like BPC-157, Thymosin Alpha-1, and KPV have shown the ability to reduce pro-inflammatory cytokine expression in animal models.
- #Inflammatory Marker immune
- Inflammatory markers are measurable blood substances whose levels rise during inflammation, allowing clinicians to detect and track systemic immune activation. The most commonly used are high-sensitivity C-reactive protein (hs-CRP), erythrocyte sedimentation rate (ESR), fibrinogen, and various cytokines including IL-6 and TNF-α. Persistently elevated markers signal chronic inflammation and predict cardiovascular and metabolic disease risk. Casey's protocols sometimes recommend tracking hs-CRP before and after a peptide cycle to objectively assess anti-inflammatory effects.
- #Injection Site pharma
- The injection site is the anatomical location chosen for each subcutaneous dose. Common sites for peptides are the abdomen (at least an inch away from the navel), the outer thigh, and the back of the upper arm. Sites are rotated each dose to prevent local tissue irritation, lumps (lipohypertrophy), or bruising. Site choice can subtly affect absorption: abdominal sites generally absorb fastest because of richer blood flow, while thigh sites absorb more slowly.
- #Injection Site Irritation pharma
- Injection site irritation includes redness, warmth, swelling, mild tenderness, itching, or a small bruise at the injection point. It's the most frequently reported side effect across peptide protocols and is usually self-limited, resolving within a few hours to a couple days. Causes include needle technique, injection depth, peptide concentration, and individual sensitivity to the diluent. Rotating injection sites, using a fresh needle each time, and warming refrigerated solution to room temperature before injecting reduce the frequency.
- #Insulin Resistance
- Insulin resistance means cells (especially in muscle, liver, and fat) don't respond strongly to insulin's signal to take up glucose. The pancreas compensates by making more insulin, which works for a while — but eventually it can't keep up and blood sugar rises. Insulin resistance is the root of type 2 diabetes, much of metabolic syndrome, and contributes to fatty liver and PCOS. Weight loss, exercise, and GLP-1s all improve it.
- #Insulin Sensitivity
- Insulin sensitivity is how strongly cells respond to a given amount of insulin. High sensitivity = small amount of insulin clears blood sugar efficiently. Sensitivity drops with weight gain, sedentary lifestyle, poor sleep, and aging. It can be restored by weight loss, resistance training, aerobic exercise, and metabolic peptides. HOMA-IR is a common simple calculation used to estimate it.
- #Insulin Syringe pharma
- Insulin syringes are designed for subcutaneous injection of insulin but are the standard tool for peptide dosing because they're inexpensive, sterile, and have very thin needles that minimize discomfort. The barrel is graduated in 'units' — 100 units equals 1 mL — which requires consumers to convert peptide dose math from micrograms to units based on their vial's concentration. The most common size is 0.5 mL (50-unit) U-100 with a 31-gauge needle, 5/16-inch length. Casey's dosage articles include conversion tables because the unit-versus-mL conversion is the most common source of dosing errors.
- #Interferon immune
- Interferons are cytokines released by cells in response to viral infection and some cancers. Type I interferons (IFN-α, IFN-β) directly fight viruses; type II (IFN-γ) coordinates immune cell activation. Interferon drugs are used for hepatitis, MS, and some cancers. Several peptides (Thymosin Alpha-1) influence interferon-related immune responses.
- #Interleukin immune
- Interleukins are a large family of cytokines (over 40 identified) that coordinate communication between immune cells. IL-6 and IL-1β are pro-inflammatory; IL-10 is anti-inflammatory; IL-2 drives T-cell proliferation; IL-17 drives some autoimmune conditions. Many newer drugs (TNF blockers, IL-6 inhibitors, IL-17 blockers) target specific interleukin pathways for inflammatory disease.
- #Intestinal Barrier gi
- The intestinal barrier is the single-cell-thick layer of gut epithelium plus tight junctions and mucus that separates the gut contents from the bloodstream. When the barrier weakens ('leaky gut' / increased intestinal permeability), bacterial fragments leak into circulation, driving systemic inflammation. It's increasingly tied to autoimmune disease, metabolic disease, and 'inflammaging.' Peptides like BPC-157 and KPV support barrier integrity.
- #Intramuscular pharmacology
- Intramuscular (IM) injections go into muscle, where rich blood flow speeds absorption compared to subcutaneous. They allow somewhat larger volumes and are common for vaccines, B12, testosterone esters, and some peptides. The trade-off versus subcutaneous is a more painful injection and slightly more variable absorption.
- #Intranasal pharma
- Intranasal administration uses the rich blood supply of the nasal mucosa to absorb a peptide without injection. Some peptides — Selank, Semax, PT-141, and certain DSIP preparations — are formulated as nasal sprays because the route can deliver them more directly to the brain via the olfactory pathway. Bioavailability is lower than injection but the route is needle-free and easy to dose. The drawback is that doses vary with how well each spray is absorbed, so consistency matters more than with injection.
- #Intravenous pharmacology
- Intravenous (IV) delivery puts a drug straight into the bloodstream, giving 100% bioavailability and near-instant onset. It's used in hospitals for fast effects, in research for precise dose control, and clinically for drugs that can't be absorbed any other way. NAD+ infusions, glutathione drips, and many cancer and immune therapies use IV delivery.
- #Irisin longevity
- Irisin is a myokine released during exercise that converts white fat into 'beige' or 'brown' fat, increasing energy expenditure and thermogenesis. It also has neuroprotective effects in animal models. Discovered in 2012, irisin remains a major target in exercise-mimetic and metabolic research, though clinical translation has been tricky.
- #Ischemia cardiovascular
- Ischemia is reduced blood flow to a tissue, depriving it of oxygen and nutrients. If brief and reversible (e.g., transient ischemic attack, stable angina), the tissue recovers. Prolonged ischemia kills cells (infarction). Many cytoprotective peptides (BPC-157, TB-500, Thymosin Beta-4) are studied for their ability to limit damage during ischemia and reperfusion.
J
- #Joint musculoskeletal
- A joint is the anatomical structure where two or more bones meet. Synovial joints (knee, hip, shoulder) include cartilage on the bone ends, ligaments around them, and a fluid-filled capsule. Joint pain is a leading reason patients seek peptide therapies — research into BPC-157 and TB-500 for tendon, ligament, and cartilage repair drives much of that interest.
K
- #Keratinocyte skin
- Keratinocytes make up about 90% of the epidermis (outer skin). They produce keratin proteins that form the tough, protective outer layer and constantly migrate outward as new cells are born below. Their health drives the skin's barrier function. GHK-Cu and other skin peptides influence keratinocyte behavior to support healing and aging skin.
- #Kidney Disease renal
- Kidney disease (CKD when chronic) is gradual loss of kidney function. The most common causes are diabetes and high blood pressure. CKD is staged 1–5 based on eGFR; stage 5 is end-stage requiring dialysis or transplant. GLP-1 receptor agonists (especially Semaglutide and Tirzepatide) and SGLT2 inhibitors have been shown to slow CKD progression in diabetes and now also in non-diabetic CKD.
- #Kisspeptin endocrine
- Kisspeptin is a hypothalamic peptide encoded by the KISS1 gene that acts upstream of GnRH and is considered the master switch of reproductive hormone signaling. When kisspeptin neurons fire, they trigger GnRH neurons, which in turn drive LH and FSH release from the pituitary. Kisspeptin-10 is a synthetic fragment of the natural peptide and is being studied for restoring hormone production after suppression and as a non-suppressive alternative to HCG. Casey's articles cover kisspeptin alongside Gonadorelin in the post-cycle recovery space.
- #Klotho longevity
- Klotho is a protein discovered in 1997 in mice whose loss causes accelerated aging. It circulates in the blood and acts both as a hormone and as a co-receptor for FGF23. People with naturally higher Klotho live longer and score better on cognitive tests. Klotho declines with age and in chronic kidney disease. It's being explored therapeutically and as a biomarker of healthy aging.
L
- #Lean Body Mass
- Lean body mass (LBM) is total weight minus fat mass. Muscle is the biggest component you can change. During weight loss, some lean mass is normally lost alongside fat — but losing too much hurts strength, metabolism, and long-term health. Combining GLP-1 therapy with resistance training and adequate protein helps preserve LBM during fat loss.
- #Left Ventricular cardiovascular
- The left ventricle is the heart's main muscular pumping chamber, ejecting oxygenated blood to the body via the aorta. Most cardiovascular disease centers on it — heart attacks usually damage left ventricle muscle, hypertension thickens its wall, and heart failure usually starts here. 'LV ejection fraction' and 'LV mass' are standard cardiology endpoints, including in peptide trials.
- #Leptin
- Leptin is a hormone made by fat tissue. It travels to the hypothalamus and signals long-term energy status — when fat stores are full, leptin rises and appetite drops. In most people with obesity, leptin is high but the brain is resistant to it ('leptin resistance'), which is part of why simply 'eating less' is so hard. Weight-loss peptides partly work by improving leptin signaling.
- #Ligament musculoskeletal
- Ligaments are dense connective tissue bands that connect bones across joints, providing stability and limiting unwanted motion. Like tendons they have low blood supply and slow healing. ACL (anterior cruciate ligament) tears typically need surgery; partial sprains can heal but often leave the joint less stable. Peptide healing research touches ligaments too, though most evidence is preclinical.
- #Ligament Healing regenerative
- Ligaments are dense connective bands linking bone to bone, and like tendons they heal through inflammation, proliferation, and remodeling but with even worse vascular supply in some locations (e.g., the ACL). Healed ligaments rarely fully regain pre-injury strength, particularly without targeted rehab. BPC-157 has the most preclinical evidence for accelerating ligament healing, with rat studies showing improved tensile strength after transection injuries. Human-grade trials remain limited.
- #Ligand pharmacology
- A ligand is any molecule that binds to a receptor. Ligands can be hormones, neurotransmitters, drugs, peptides, or signaling proteins. The receptor recognizes the ligand by shape and chemistry, and binding triggers downstream effects (or blocks them, if the ligand is an antagonist). Most peptide drugs are designed-or-discovered ligands for specific receptors.
- #Lipogenesis
- Lipogenesis is the synthesis of fatty acids and triglycerides from acetyl-CoA precursors (mostly derived from carbohydrates) in the liver and adipose tissue. It's regulated by insulin and the transcription factor SREBP-1c. A chronically high-carbohydrate, high-calorie diet drives de novo lipogenesis in the liver, contributing to non-alcoholic fatty liver disease (NAFLD). AOD-9604 and certain growth-hormone-pathway peptides may help by reducing lipogenesis while simultaneously promoting lipolysis.
- #Lipolysis
- Lipolysis is the breakdown of triglycerides stored in fat cells (adipocytes) into free fatty acids and glycerol, which are then released into the bloodstream and used as fuel. The process is triggered by hormones — catecholamines (adrenaline), growth hormone, glucagon, and natriuretic peptides — acting through hormone-sensitive lipase. Insulin suppresses lipolysis, which is why insulin resistance and high-carbohydrate eating make fat loss harder. Growth-hormone-releasing peptides drive lipolysis as one of their main mechanisms, and Tesamorelin specifically reduces visceral fat through this pathway.
- #Long-Term Safety research
- Long-term safety encompasses adverse effects that emerge over years of exposure, including cancer risk, organ toxicity, cardiovascular events, and effects on fertility and offspring. Many research peptides have weak or absent long-term safety data because the few human trials that exist are short and small. Casey's content consistently flags this gap: BPC-157, TB-500, Epitalon, and most growth-hormone secretagogues lack large-scale human longitudinal data. Approved peptides like Semaglutide and Tesamorelin have more long-term data because of their regulatory pathway.
- #Longevity longevity
- Longevity research aims to extend not just lifespan but 'healthspan' — the years lived in good health. Major intervention themes include caloric restriction, fasting, exercise, NAD+ boosters, senolytics, mTOR inhibition (rapamycin), and metabolic peptides. Many peptides — MOTS-c, Epitalon, GHK-Cu, Klotho — are studied for one or more longevity mechanisms.
- #Longitudinal methodology
- A longitudinal study follows the same group of people over time, measuring outcomes at multiple points. They reveal trends, cause-and-effect timing, and individual change in ways cross-sectional studies can't. The Framingham Heart Study and Nurses' Health Study are famous examples that produced decades of cardiovascular and nutritional insight. They're expensive but uniquely informative.
- #Luteinizing Hormone (LH) endocrine
- Luteinizing hormone (LH) is released from the anterior pituitary in response to gonadotropin-releasing hormone (GnRH) from the hypothalamus. In men, LH stimulates Leydig cells in the testes to produce testosterone; in women, an LH surge mid-cycle triggers ovulation and supports progesterone production. Peptides like Kisspeptin-10 and Gonadorelin restore LH signaling, which is why they're studied for hormone recovery after suppression. Suppressed LH is a hallmark of secondary hypogonadism and a common finding after prolonged anabolic steroid use.
- #Lymphocyte immune
- Lymphocytes are the white blood cells responsible for adaptive immunity. T-cells coordinate immune attacks and kill infected cells; B-cells produce antibodies; natural killer (NK) cells destroy stressed or cancerous cells. They circulate through blood and lymph and stage in lymph nodes. Peptides like Thymosin Alpha-1 modulate lymphocyte function and are studied for immune support during infection or cancer treatment.
- #Lyophilized Powder pharma
- Lyophilization is a freeze-drying process that removes water from a peptide solution under vacuum, leaving a stable powder that can be stored at room temperature for months and refrigerated for years. Almost every research peptide ships as lyophilized powder in a glass vial because liquid peptides degrade quickly. Before use, the powder is reconstituted by injecting bacteriostatic water through the stopper, swirling gently, and refrigerating. Quality matters — humidity exposure, heat during shipping, or repeated freeze-thaw cycles can degrade the peptide and reduce potency.
M
- #Macrophage immune
- Macrophages are immune cells that engulf and digest pathogens, dead cells, and cellular debris ('phago' = eat, 'cyte' = cell). They also switch personalities: 'M1' macrophages drive inflammation to fight infection, 'M2' macrophages tamp down inflammation and promote healing. Many peptides — BPC-157, TB-500, KPV — work in part by nudging macrophages toward the repair phenotype.
- #Major Adverse Cardiovascular Events cardiovascular
- MACE (major adverse cardiovascular events) is a composite trial endpoint, typically including cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke. It bundles related serious events into one outcome that's large enough to power a trial in a reasonable time frame. Some MACE definitions also include hospitalization for heart failure or unstable angina. It's the gold standard for cardiovascular drug approval.
- #Mechanism of Action (MOA) pharma
- Mechanism of action (MOA) is the specific biochemical interaction by which a drug, peptide, or other intervention produces its pharmacological effect. A complete MOA description names the molecular target (receptor, enzyme, ion channel), the type of interaction (agonism, antagonism, inhibition), and the downstream cellular consequences. Knowing the MOA helps predict efficacy, side effects, and interactions. Casey's articles typically open with the MOA for each peptide because consumer confusion about effects usually traces back to misunderstanding what the peptide is actually doing at the cellular level.
- #Melanin skin
- Melanin is the pigment produced by melanocytes that determines skin, hair, and eye color and absorbs UV radiation. Two main types — eumelanin (brown/black) and pheomelanin (red/yellow) — combine in different ratios. Melanin production is triggered by sunlight (via α-MSH signaling) and by melanocortin-receptor-activating peptides like Melanotan-1 and Melanotan-2.
- #Melanocyte skin
- Melanocytes are pigment-producing cells in the basal layer of the epidermis and in hair follicles. They make melanin and pass it to surrounding skin cells, providing UV protection and color. Melanoma arises from melanocytes. Melanotan peptides activate melanocortin receptors on melanocytes to stimulate melanin production, which is why they tan skin (and is also linked to safety concerns regarding mole changes).
- #Melatonin neural
- Melatonin is a hormone released by the pineal gland in response to darkness, signaling sleep onset and synchronizing the circadian rhythm. It's also a powerful antioxidant and has anti-inflammatory effects. Low-dose supplements (0.3–1 mg, sometimes higher) are used for jet lag, shift work, and some insomnia. Brighter, well-timed daylight exposure is the strongest natural lever for healthy melatonin patterns.
- #Meta-Analysis methodology
- A meta-analysis statistically combines results from multiple independent studies on the same question to produce a pooled effect estimate. Done well, meta-analyses are the most reliable source of evidence — they smooth out random variation between trials. Done poorly (combining studies that shouldn't be combined), they can mislead. They're a core tool in evidence-based medicine.
- #Metabolic Flexibility
- Metabolic flexibility is the ability of cells — primarily skeletal muscle — to switch fuel preference between glucose and fatty acids based on nutrient availability and energy demand. Metabolically flexible people burn fat well during fasting and exercise and burn glucose well after meals. Metabolic inflexibility is a hallmark of insulin resistance, type 2 diabetes, and obesity, where mitochondria can't readily switch fuels. Peptides like MOTS-c, growth-hormone secretagogues, and exercise mimetics are studied for restoring metabolic flexibility.
- #Metabolic Rate
- Metabolic rate is the rate of energy expenditure, usually measured as calories per day. Resting metabolic rate (RMR) accounts for 60–75% of total daily energy expenditure and is influenced primarily by lean body mass, age, sex, thyroid hormone, and mitochondrial efficiency. Activity, the thermic effect of food, and non-exercise activity thermogenesis (NEAT) make up the rest. Several peptides — Tesamorelin, AOD-9604, MOTS-c — are studied for modest increases in metabolic rate through different mechanisms, primarily by improving lean mass and fat oxidation.
- #Metabolic Syndrome
- Metabolic syndrome is diagnosed when someone has at least 3 of: large waist circumference, elevated triglycerides, low HDL cholesterol, high blood pressure, and high fasting glucose. It signals underlying insulin resistance and dramatically raises risk of type 2 diabetes and cardiovascular disease. Weight loss, exercise, and metabolic peptides all address the cluster as a whole.
- #Metabolism
- Metabolism is the sum of biochemical processes that maintain life: catabolism breaks larger molecules (food, stored fat, glycogen) into energy and smaller building blocks, while anabolism uses energy to build proteins, lipids, and nucleic acids. The basal metabolic rate (BMR) is what the body burns at rest. Hormones — thyroid, growth hormone, cortisol, insulin, glucagon, and leptin — set the tempo. Many peptides in Casey's catalog target metabolism directly (Tesamorelin, Semaglutide, AOD-9604, MOTS-c) or indirectly through growth hormone, mitochondrial function, or appetite signaling.
- #Methylation molecular
- Methylation is a chemical process in which a methyl group is added to DNA bases or to proteins. On DNA, it usually quiets gene expression. Methylation patterns shift with age, diet (especially folate, B12, choline), and environment. The most validated biological age tests (Horvath clock, GrimAge) read methylation patterns. Healthy methylation supports detoxification, neurotransmitter balance, and cellular repair.
- #Microbiome gi
- The microbiome is the collection of all microorganisms (and their genetic material) in or on a body site — gut, skin, mouth, vagina, lung. The gut microbiome is by far the most studied. Disruptions ('dysbiosis') are linked to obesity, IBD, autoimmune disease, allergies, and depression. Modulators include diet, prebiotics, probiotics, fecal microbiota transplant, and some peptides.
- #Mitochondria cell-bio
- Mitochondria are organelles inside almost every cell of your body. They convert food and oxygen into ATP, the energy currency your cells use to do everything. They also regulate cell death, hormone production, and inflammation. As we age, mitochondria become less efficient — a process tied to fatigue, metabolic disease, and many features of aging. Peptides like MOTS-c, SS-31, and Humanin are studied specifically for mitochondrial health.
- #Mitochondrial Function cell-bio
- Mitochondrial function describes the capacity of mitochondria to produce ATP via oxidative phosphorylation, manage reactive oxygen species, and signal cell health. It depends on mitochondrial DNA integrity, electron transport chain efficiency, membrane potential, and the balance of biogenesis with mitophagy. Declining mitochondrial function underlies fatigue, insulin resistance, sarcopenia, neurodegeneration, and aging. Peptides studied for mitochondrial support include MOTS-c (a mitochondrial-derived peptide), SS-31 (mitochondrial membrane stabilizer), Humanin, and growth-hormone-axis peptides.
- #Mitophagy cell-bio
- Mitophagy is the process by which cells identify and break down damaged or worn-out mitochondria. It's a specialized form of autophagy that keeps the mitochondrial pool healthy. When mitophagy slows down (as happens with aging), damaged mitochondria accumulate and contribute to inflammation, fatigue, and metabolic dysfunction. Boosting mitophagy is a major target for longevity peptides like Urolithin A and MOTS-c.
- #mTOR molecular
- mTOR (mechanistic target of rapamycin) is a protein kinase that integrates nutrient and growth signals to decide whether cells should grow or conserve. Active mTOR drives protein synthesis, muscle growth, and cell division. Inhibiting mTOR (via fasting, exercise, or the drug rapamycin) extends lifespan in animals and activates autophagy. AMPK and mTOR are opposing arms — AMPK conserves, mTOR builds — and peptides influencing this balance are widely studied for longevity and metabolism.
- #Muscle Hypertrophy tissue
- Muscle hypertrophy is the enlargement of skeletal muscle fibers through accretion of contractile protein, sarcoplasmic content, and connective tissue. It's driven by mechanical tension from resistance training, metabolic stress, and adequate protein and energy intake, with the mTOR pathway integrating these signals. Hypertrophy is distinct from hyperplasia (increase in fiber number). Growth-hormone-axis peptides offer indirect support by raising IGF-1 and lean-tissue building signaling, but no peptide currently provides hypertrophy comparable to consistent resistance training.
- #Muscle Protein Synthesis tissue
- Muscle protein synthesis (MPS) is the rate at which amino acids are incorporated into skeletal muscle proteins, principally myofibrillar contractile proteins. Net muscle gain occurs when MPS exceeds muscle protein breakdown over time. MPS is acutely stimulated by resistance training, dietary protein (especially leucine), insulin, and growth hormone/IGF-1 axis activation. Peptides that elevate growth hormone and IGF-1 — Ipamorelin, Sermorelin, Tesamorelin, CJC-1295 — can modestly support MPS, but training stimulus and protein intake remain the primary levers.
- #Muscle Wasting musculoskeletal
- Muscle wasting (atrophy) is loss of muscle mass that can occur from disuse (bed rest, cast immobilization), chronic illness (cancer, heart failure, COPD), or aggressive aging (sarcopenia). It worsens recovery, increases mortality, and is hard to reverse once severe. Peptides promoting muscle protein synthesis (growth hormone secretagogues, IGF-1 modulators) are studied for prevention and recovery.
- #Musculoskeletal tissue
- Musculoskeletal refers to the integrated system of muscles, bones, tendons, ligaments, joints, and fascia. Musculoskeletal injury and pain are the most common reasons people seek out research peptides like BPC-157 and TB-500. The system also includes cartilage and the synovial structures of joints; aging produces a mix of sarcopenia, osteopenia, tendinopathy, and osteoarthritis that collectively reduce function. Most peptide protocols in this space target the connective-tissue components more than the bone or cartilage components.
- #Myocardial Infarction cardiovascular-disease-mention
- Myocardial infarction (MI) is the death of heart muscle from prolonged ischemia, usually because a coronary artery is blocked by a plaque rupture and clot. Symptoms include chest pain, shortness of breath, sweating, and arm or jaw pain. Modern treatment (rapid stenting + medications) has dramatically improved survival, but the damaged tissue still scars. Cardiac regeneration research (including peptide-based approaches) targets minimizing or healing this scar.
- #Myokine musculoskeletal
- Myokines are signaling molecules secreted by muscle cells, especially during contraction. They include IL-6 (anti-inflammatory in this context), BDNF, irisin, and FGF21. Myokines explain many of exercise's distant benefits — better mood, sharper cognition, improved metabolism, reduced cancer risk. Exercise mimetic peptides aim to trigger some myokine release without the workout.
N
- #NAD+ longevity
- NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell. It accepts and donates electrons in metabolism (turning food into ATP) and serves as fuel for sirtuins and DNA-repair enzymes. NAD+ levels fall by 50% or more from young adulthood to old age, contributing to mitochondrial decline and reduced repair capacity. NMN, NR, and NAD+ infusions are studied for raising tissue NAD+.
- #NADH molecular
- NADH is the reduced form of NAD+, carrying electrons stripped from food during digestion to the mitochondria, where those electrons drive ATP production. The NAD+/NADH ratio reflects cellular energy status: high NAD+ means cells are 'hungry' and stress-resistance pathways turn on; high NADH means cells are well-fed. Many longevity and metabolic strategies aim to keep the ratio tilted toward NAD+.
- #NAFLD
- NAFLD (non-alcoholic fatty liver disease) — increasingly called MASLD (metabolic-associated steatotic liver disease) — describes fat build-up in liver cells not caused by alcohol. It affects an estimated 25–30% of adults globally, often without symptoms. Some progress to NASH (inflamed, scarring liver) and eventually cirrhosis or liver cancer. GLP-1s, FGF21 analogs, and several other peptides are in trials for NAFLD/NASH.
- #NASH
- NASH (non-alcoholic steatohepatitis), now also called MASH, is the more aggressive form of fatty liver disease — fat plus inflammation plus liver cell damage. About 20–25% of people with NAFLD progress to NASH, which can lead to fibrosis, cirrhosis, and liver cancer over years to decades. Resmetirom became the first FDA-approved NASH drug in 2024; multiple peptides (Tirzepatide, Retatrutide, FGF21 analogs) are in trials.
- #Naturally Occurring Peptide molecular
- A naturally occurring peptide is a peptide produced by living organisms, including hormones (insulin, GLP-1, growth hormone, oxytocin), antimicrobial peptides (LL-37, defensins), and intracellular signaling peptides (humanin, MOTS-c). Many therapeutic peptides are identical to or close analogs of naturally occurring peptides; some have been chemically modified (e.g., D-amino acids, fatty-acid conjugation) to improve stability or half-life. The distinction matters in marketing because 'natural' is often invoked but doesn't by itself imply safety or efficacy.
- #Nausea gi
- Nausea is the unpleasant sensation of imminent vomiting. With GLP-1 agonists and dual/triple agonists, nausea is the most frequently reported adverse effect, occurring in 20–45% of patients depending on dose and agent, and is concentrated in the first weeks of each dose escalation. It results from slowed gastric emptying and central effects on brainstem nausea pathways. Mitigation includes slower dose titration, smaller meals, avoiding fatty foods, and adequate hydration. Persistent vomiting can produce dehydration and electrolyte loss requiring medical attention.
- #Necrosis cell-bio
- Necrosis is unplanned cell death from external trauma, infection, lack of blood flow, or toxins. Unlike apoptosis (which is tidy), necrosis bursts the cell open and releases inflammatory contents that injure neighbors. Heart attacks and strokes kill tissue through ischemic necrosis. Cytoprotective peptides like BPC-157 and TB-500 are studied for their ability to reduce necrosis after ischemic injury.
- #Neurodegeneration neural
- Neurodegeneration is the gradual death of neurons in specific brain regions, producing diseases like Alzheimer's (cortex and hippocampus), Parkinson's (substantia nigra), Huntington's (striatum), and ALS (motor neurons). Causes are mixed — protein aggregation, mitochondrial failure, neuroinflammation, oxidative stress — and treatments are mostly symptomatic. Neuroprotective peptides are studied for slowing or preventing these processes.
- #Neurogenesis neural
- Neurogenesis is the formation of new neurons from neural stem cells. Once thought impossible in adult humans, it's now known to continue in certain brain regions (especially the hippocampus) throughout life. Exercise, sleep, BDNF, and certain peptides (Semax, Cerebrolysin) increase neurogenesis. Stress, depression, and aging reduce it. It's linked to learning, memory, and emotional resilience.
- #Neuroinflammation neural
- Neuroinflammation is activation of the brain's immune cells (microglia and astrocytes) producing inflammatory cytokines inside the central nervous system. Acutely it's protective (clearing infection or damage); chronically it drives neurodegeneration and is implicated in Alzheimer's, Parkinson's, depression, long COVID brain fog, and chronic pain. Anti-inflammatory peptides and lifestyle interventions are key research areas.
- #Neuroprotection neural
- Neuroprotection is any strategy that prevents or limits the death of neurons. Targets include reducing oxidative stress, excitotoxicity, inflammation, and apoptosis in the brain. Peptides studied for neuroprotection include Semax, Selank, Cerebrolysin, and BDNF mimetics. The field looks at acute injury (stroke, TBI) and chronic neurodegeneration (Alzheimer's, Parkinson's).
- #Neurotransmitter neural
- A neurotransmitter is a signaling molecule released from one neuron's axon terminal that binds receptors on the next neuron's dendrite, transmitting the signal across the synaptic cleft. Major neurotransmitters include dopamine (motivation, reward), serotonin (mood, gut), GABA (inhibition, calm), glutamate (excitation, learning), acetylcholine (muscle, attention), and norepinephrine (alertness, stress). Some peptides (Selank, Semax, Noopept) modulate neurotransmitter systems and are studied for cognitive and anxiolytic effects.
- #Neutrophil immune
- Neutrophils are short-lived immune cells that swarm sites of injury or infection within minutes. They release enzymes and reactive oxygen species to kill microbes — but the same arsenal damages healthy tissue if they linger too long. Resolving neutrophil-driven inflammation is part of how wounds transition from injury to healing. Peptides like BPC-157 and KPV reduce excess neutrophil activity in injured tissue.
- #Nitric Oxide cardiovascular
- Nitric oxide (NO) is a small gas molecule produced by endothelial cells that signals nearby smooth muscle to relax, widening blood vessels. It's central to circulation, blood pressure regulation, exercise capacity, and erectile function. Drugs for ED (sildenafil) and certain peptides work by enhancing or preserving NO signaling. NO availability falls with aging and endothelial dysfunction.
- #Nrf2 Pathway molecular
- Nrf2 (nuclear factor erythroid 2–related factor 2) is a transcription factor that activates dozens of antioxidant and detox genes when cells sense oxidative stress. It's the master regulator of the cell's defensive response. Boosting Nrf2 activity is a research focus for chronic disease, aging, and inflammation. Compounds in cruciferous vegetables (sulforaphane) and several peptides activate this pathway.
O
- #Obesity
- Obesity is excess body fat sufficient to harm health, generally defined as BMI ≥30 (though body composition and ethnicity matter). Causes are complex — genetics, environment, hormones, gut microbiome, sleep, stress — and willpower alone rarely succeeds. The AMA, WHO, and most medical bodies now classify obesity as a chronic disease. GLP-1 receptor agonists and dual/triple agonists have transformed treatment in the past 5 years.
- #Open-Label methodology
- An open-label trial doesn't blind participants or researchers to the treatment assignment. It's used for safety follow-on studies (after a blinded RCT), single-arm pilot studies, or when blinding isn't feasible. Open-label results can overestimate effects due to expectation bias, so they're usually not enough on their own for drug approval.
- #Oral Bioavailability pharmacology
- Oral bioavailability is how much of an oral dose makes it into the systemic circulation. Most peptides have very low oral bioavailability (under 1–2%) because stomach acid and gut enzymes digest them like food. Special formulations (penetration enhancers, enteric coatings, novel carriers) are being developed to improve this — oral Semaglutide is the first commercially successful example.
- #Osteoarthritis musculoskeletal-disease-mention
- Osteoarthritis (OA) is degenerative joint disease — progressive loss of cartilage, bone changes, and joint inflammation. It's the leading cause of disability in older adults. Common in knees, hips, hands, and spine. Conventional treatments are limited (weight loss, exercise, NSAIDs, eventually joint replacement). Peptides supporting cartilage and joint health (BPC-157, TB-500) are under research but with limited human evidence.
- #Oxidative cell-bio
- Oxidative in biology usually refers to reactions involving oxygen and especially to oxidative stress — the imbalance between reactive oxygen species (ROS) production and antioxidant defenses. Oxidative stress damages proteins, lipids, and DNA, contributing to inflammation, aging, and disease. Mitochondria are both the major ROS source and a primary damage target. Antioxidant peptides — SS-31, glutathione precursors, and the natural carnosine pathway — aim to restore redox balance.
- #Oxidative Stress cell-bio
- Oxidative stress happens when reactive oxygen species (ROS) — unstable molecules that strip electrons from proteins, fats, and DNA — outpace your antioxidant defenses. Some ROS is normal and even useful for signaling, but chronic excess damages tissue and accelerates aging, heart disease, diabetes, and neurodegeneration. Peptides like GHK-Cu, Glutathione, and SS-31 are studied for their ability to reduce oxidative stress directly or boost the body's own antioxidant systems.
P
- #Parkinson's neural-disease-mention
- Parkinson's disease (PD) is caused by progressive loss of dopamine-producing neurons in the substantia nigra. Symptoms include resting tremor, bradykinesia (slow movement), rigidity, and postural instability; non-motor symptoms include constipation, sleep changes, depression, and cognitive decline. Levodopa remains the most effective treatment; deep brain stimulation helps some. Research into neuroprotective peptides for PD is ongoing.
- #Pentadecapeptide molecular
- Pentadecapeptide is a peptide chain made of 15 amino acids. The term appears in peptide research mainly because of BPC-157, formally called 'stable gastric pentadecapeptide BPC 157,' which is a 15-amino-acid sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) derived from a partial sequence of a protective protein found in human gastric juice. The 'pentadecapeptide' label distinguishes BPC-157 from longer or shorter related sequences in the research literature.
- #Pharmacodynamics pharmacology
- Pharmacodynamics (PD) describes the relationship between drug concentration at the site of action and the effect it produces. While pharmacokinetics is about where the drug is and how much is there, PD is about what it actually does. PK + PD together determine the dose and schedule that produces a meaningful clinical effect.
- #Pharmacokinetics pharmacology
- Pharmacokinetics (PK) describes a compound's journey through the body: Absorption (getting in), Distribution (where it travels), Metabolism (how it's broken down), Excretion (how it leaves). PK determines how often you have to dose and at what strength. For peptides, PK is especially important because most are broken down quickly in the gut — which is why they're usually injected.
- #Phase 1 methodology
- Phase 1 trials are the first studies of a new drug in humans, typically in 20–80 healthy volunteers (or patients for some drug types). The focus is safety, tolerability, pharmacokinetics, and identifying the maximum tolerated dose. Efficacy is a secondary observation. Most candidates fail in or before phase 1.
- #Phase 2 methodology
- Phase 2 trials test the drug in patients with the target condition (typically 100–300 people) to evaluate efficacy and refine dosing. They're often randomized and placebo-controlled. Roughly 30% of phase 2 candidates advance to phase 3. Many peptide candidates discussed in research are in phase 2.
- #Phase 3 methodology
- Phase 3 trials are large randomized controlled trials (usually 1,000+ participants) designed to confirm efficacy, monitor safety, and gather data for regulatory approval. They're the most expensive and consequential stage of development. Successful phase 3 is usually required for FDA approval. Cardiovascular outcomes trials (CVOTs) for diabetes drugs are large phase 3 trials.
- #Phosphorylation molecular
- Phosphorylation is the addition of a phosphate group to a protein by an enzyme called a kinase. It's one of the fastest and most common ways cells change protein behavior — a single phosphorylation event can turn an enzyme on or off, change where it goes, or who it binds. Most signaling pathways (AMPK, mTOR, MAPK) work through phosphorylation cascades. Many peptides initiate these cascades by binding receptors that activate kinases.
- #Photoaging skin
- Photoaging is the premature aging of skin caused by UV exposure, distinct from chronological aging. It produces wrinkles, hyperpigmentation, telangiectasias, and roughened texture. UV damages collagen and elastin, increases melanin unevenly, and generates oxidative stress. Sunscreen is the cornerstone of prevention; topical peptides (GHK-Cu, Matrixyl), retinoids, and antioxidants are studied for repair.
- #Pigmentation skin
- Pigmentation refers to skin or hair color produced by melanin. Hyperpigmentation (darkening) includes age spots, melasma, and post-inflammatory marks. Hypopigmentation (lightening) includes vitiligo and post-laser changes. Peptides — both pigment-promoting (Melanotan) and pigment-modulating (GHK-Cu) — are studied for cosmetic and medical pigmentation applications.
- #Pituitary endocrine
- The pituitary is a small gland sitting below the hypothalamus that secretes hormones directing the thyroid, adrenals, gonads, growth, and lactation. It's divided into anterior (makes GH, ACTH, TSH, LH, FSH, prolactin) and posterior (releases oxytocin and vasopressin). It's the target of GH secretagogue peptides and the source of many hormones modulated by metabolic and longevity therapies.
- #Pituitary Gland endocrine
- The pituitary gland sits in a bony pocket at the base of the brain and is often called the 'master gland' because it controls the thyroid, adrenals, gonads, and growth via downstream hormones. The anterior pituitary secretes growth hormone, prolactin, ACTH, TSH, LH, and FSH; the posterior pituitary releases oxytocin and vasopressin. Almost every growth-hormone-related peptide protocol — Sermorelin, Tesamorelin, Ipamorelin, CJC-1295 — works by stimulating receptors on pituitary cells. Casey's articles often discuss pituitary feedback because over-stimulation can blunt the gland's response.
- #Placebo-Controlled methodology
- A placebo-controlled trial gives the control group a dummy version (saline injection, sugar pill) indistinguishable from the active treatment. Because people improve simply from expecting to (the placebo effect), comparing to placebo isolates the true pharmacological effect. Placebo response can be sizable, especially for pain, mood, and subjective outcomes, which is why placebo control is essential.
- #Platelet cardiovascular
- Platelets are cell fragments produced in bone marrow that circulate in blood and rush to sites of injury to form clots. Beyond clotting, they release growth factors (PDGF, VEGF, TGF-β) that recruit other cells and start the healing cascade. This is why platelet-rich plasma (PRP) injections are used in orthopedics. Several peptides also work synergistically with platelet-derived signals during tissue repair.
- #Post-Cycle Therapy (PCT) endocrine
- Post-cycle therapy (PCT) is the systematic restoration of endogenous hormone production after a cycle of hormone-suppressing drugs (anabolic steroids, SARMs) or peptide protocols that suppress feedback. The HPG axis (hypothalamus-pituitary-gonadal) requires reactivation via pulsatile GnRH-like signaling — Gonadorelin and Kisspeptin-10 mimic this — and downstream LH stimulation via HCG. PCT also addresses recovery of mood, libido, energy, and lean mass during the readjustment period. Casey's content draws careful distinctions between peptide-based PCT and conventional SERM-based PCT.
- #PPAR molecular
- Peroxisome proliferator-activated receptors (PPARs — α, δ, γ) are nuclear receptors that turn on genes involved in fat metabolism, glucose handling, and inflammation. PPAR-α drives fat burning, PPAR-γ drives fat storage and insulin sensitivity, PPAR-δ governs muscle energy use. Diabetes drugs (TZDs) target PPAR-γ; exercise mimetics often target PPAR-δ. Several peptides modulate PPAR activity as part of their metabolic effects.
- #Preclinical methodology
- Preclinical research includes lab studies in cells, tissues, and animal models that establish a drug's mechanism, dosing range, and basic safety before any human exposure. Many promising preclinical findings don't translate to humans, so 'studies show' from animals isn't proof of human benefit. Most early peptide claims rest mainly on preclinical evidence.
- #Primary Endpoint methodology
- The primary endpoint is the prespecified outcome a trial is designed and powered to evaluate. It's what determines if the trial 'succeeds.' For obesity trials it's often percent body weight change; for diabetes, HbA1c; for cardiovascular trials, MACE. Secondary endpoints provide supporting information but don't carry the same weight unless prespecified for hierarchical testing.
- #Pro-Inflammatory immune
- Pro-inflammatory means promoting inflammation. Pro-inflammatory cytokines (IL-1, IL-6, TNF-α) ramp up immune responses. Diets high in refined carbohydrates, excess body fat, smoking, and chronic stress all push the body toward a pro-inflammatory state. Reducing pro-inflammatory drivers is part of why weight loss, exercise, and some peptides improve so many conditions at once.
- #Progenitor Cell cell-bio
- Progenitor cells sit one step below stem cells in the hierarchy. They've already committed to a tissue type (heart, blood, nerve) but haven't fully differentiated. They divide more rapidly than stem cells and are the main workforce for tissue repair. Epicardial progenitor cells, for example, can become coronary blood vessels, smooth muscle, and possibly new heart muscle when activated by injury signals or peptides like Thymosin Beta-4.
- #Progesterone endocrine
- Progesterone is a steroid hormone produced mainly by the corpus luteum of the ovary in the second half of the menstrual cycle, by the placenta during pregnancy, and in small amounts by the adrenal glands in both sexes. It opposes some of estrogen's actions, calms the nervous system through its metabolite allopregnanolone, and supports endometrial stability. Progesterone levels fall sharply at menopause, contributing to sleep and mood symptoms. Peptide protocols don't typically target progesterone directly, but its decline is part of the broader hormonal aging picture Casey writes about.
- #Proliferation cell-bio
- Proliferation is the increase in cell number through division. It's essential during growth, healing, and immune responses, but uncontrolled proliferation causes tumors and excess scarring. Healing peptides like BPC-157 and GHK-Cu boost proliferation of helpful cells (fibroblasts, endothelial cells) during repair. The balance of proliferation, differentiation, and apoptosis defines whether tissue heals cleanly or scars excessively.
- #Protein Synthesis molecular
- Protein synthesis is the multi-step process by which cells produce proteins from amino acids, involving transcription of DNA to mRNA, translation of mRNA by ribosomes, and folding into the functional protein. The mTOR pathway is a major regulator and integrator of nutrient and growth-factor signals that determine the rate of synthesis. Insulin, leucine, IGF-1, and resistance training all stimulate skeletal muscle protein synthesis. Growth-hormone-axis peptides support overall protein synthesis indirectly via IGF-1.
- #Psoriasis skin-disease-mention
- Psoriasis is a chronic autoimmune skin disease producing well-defined red plaques covered with silvery scales, most often on elbows, knees, scalp, and lower back. It's driven by overactive T-cells and IL-17/IL-23 signaling and is associated with psoriatic arthritis and metabolic disease. Modern biologics (IL-17 and IL-23 inhibitors) are highly effective. Some peptides under research target the same pathways.
- #Pulsatile pharma
- Pulsatile release refers to the natural pattern of intermittent bursts of hormone secretion separated by quiet intervals. Growth hormone, LH, FSH, ACTH, and several other pituitary hormones are released this way, with the pulse rhythm itself being part of the signal. Continuous (non-pulsatile) exposure causes receptor desensitization and can paradoxically shut the axis down. GHRH-analog and ghrelin-mimetic peptides are typically dosed to mimic or enhance natural pulses rather than to flood receptors continuously.
R
- #Randomized Controlled Trial methodology
- A randomized controlled trial (RCT) randomly assigns participants to receive the treatment or a control (often placebo). Randomization balances unknown factors between groups so any difference in outcome can be attributed to the treatment itself. RCTs are the strongest single source of evidence for whether something works, and form the backbone of FDA approvals.
- #Reactive Oxygen Species cell-bio
- Reactive oxygen species (ROS) are byproducts of normal cellular metabolism, especially from mitochondria. At low levels they help with cell signaling and immune defense. At high levels they damage DNA, proteins, and cell membranes. ROS overload is a feature of aging, diabetes, neurodegeneration, and cardiovascular disease. Antioxidant peptides like Glutathione neutralize ROS, while peptides like SS-31 reduce ROS production at the mitochondrial source.
- #Receptor pharmacology
- A receptor is a protein that binds a specific molecule (the ligand) and then triggers a change inside the cell. Receptors are how hormones, neurotransmitters, drugs, and peptides communicate with cells. Most peptides work by binding to a specific receptor — GLP-1s bind the GLP-1 receptor, growth hormone secretagogues bind GHSR, and so on. The receptor type determines what tissue responds and how.
- #Receptor Agonist molecular
- A receptor agonist is a ligand that binds a receptor and activates the same downstream signaling as the natural (endogenous) ligand would. Agonists can be 'full' (producing the maximal response possible at that receptor), 'partial' (producing less than the maximum), or 'biased' (preferentially activating some downstream pathways over others). Most therapeutic peptides are agonists: Semaglutide at the GLP-1 receptor, Tirzepatide at GLP-1 and GIP receptors, Ipamorelin at the ghrelin receptor. The opposite is an antagonist, which blocks the receptor without activating it.
- #Receptor Desensitization molecular
- Receptor desensitization is the reduction in a receptor's responsiveness after prolonged or repeated activation. Mechanisms include receptor phosphorylation, internalization off the cell surface, and downregulation of receptor gene expression. The phenomenon underlies why pulsatile or cycled dosing of growth-hormone-releasing peptides (Sermorelin, Tesamorelin, Ipamorelin) typically outperforms continuous dosing: receptors need recovery time to re-sensitize. It's also why GHRH analog protocols often use 5-days-on / 2-days-off cycles or 8-weeks-on / 4-weeks-off cycles.
- #Red Blood Cell (Erythrocyte) cardiovascular
- Red blood cells (erythrocytes) are biconcave anucleate cells filled with hemoglobin that transport oxygen from the lungs to peripheral tissues and return carbon dioxide for exhalation. They're produced in bone marrow under the control of erythropoietin (EPO) from the kidneys and live about 120 days before being cleared by the spleen. Hemoglobin and hematocrit on a blood panel reflect red cell mass. Some growth-hormone-axis peptides (Tesamorelin in particular) can modestly raise hematocrit, and peptide-related labs sometimes monitor this.
- #Regeneration cell-bio
- Regeneration is true tissue replacement — new functional tissue, not just scar. Humans regenerate some tissues well (skin, liver, gut lining) and others poorly (heart, spinal cord, joints). Regenerative medicine aims to push the poor regenerators toward true repair. Peptides like BPC-157 (gut and tendon), TB-500 (heart and connective tissue), and GHK-Cu (skin) are studied for their pro-regenerative effects.
- #Regenerative Medicine regenerative
- Regenerative medicine is the field aimed at restoring function to damaged tissues and organs using stem cells, growth factors, peptide signals, biomaterials, or tissue-engineered constructs. It overlaps with rehabilitation medicine, transplantation, and orthopedics. Peptide therapies sit within this field by influencing endogenous repair signaling — BPC-157, TB-500, and GHK-Cu are the most-discussed in this space. Human-grade clinical trials are still catching up with the volume of preclinical evidence and consumer interest.
- #Regulatory Approval research
- Regulatory approval is the process by which a national authority (FDA in the US, EMA in Europe, MHRA in the UK, PMDA in Japan) reviews clinical evidence and authorizes a drug for marketing for specific indications. Most research peptides discussed by Casey's audience — BPC-157, TB-500, Epitalon, MOTS-c — do not have regulatory approval; some (Tesamorelin, Semaglutide, Liraglutide, PT-141) do. The legal status implications are significant: approved drugs are prescribed and dispensed by pharmacies, while unapproved peptides are sold for 'research use only.'
- #Reperfusion cardiovascular
- Reperfusion is the restoration of blood flow to ischemic tissue (e.g., after a stent opens a blocked coronary artery). It's essential — without it, the tissue dies. But the sudden return of oxygen produces a burst of reactive oxygen species and inflammation called 'reperfusion injury' that worsens the original damage. Peptides being studied for protection during reperfusion include Thymosin Beta-4 and BPC-157.
- #Research Use Only (RUO) research
- Research Use Only (RUO) is a regulatory designation indicating a substance is sold for in-vitro laboratory or research use and is not approved for diagnostic or therapeutic use in humans or animals. Most online peptide suppliers ship under RUO labels because the compounds (BPC-157, TB-500, Epitalon, Semax) have not received FDA approval for human therapeutic indications. The RUO label has legal consequences for the buyer and the seller; Casey's articles consistently flag that RUO peptides used in humans operate outside the regulated medical system.
S
- #Sarcopenia musculoskeletal-disease-mention
- Sarcopenia is the progressive loss of muscle mass, strength, and function with age. It typically starts around age 30 and accelerates after 60. It contributes to falls, fractures, disability, and metabolic dysfunction. Resistance training and adequate protein remain the cornerstone treatments; growth hormone secretagogues, IGF-1 modulators, and exercise mimetics are studied as adjuncts. Preserving lean mass during weight loss matters for the same reasons.
- #Satiety
- Satiety is the biological signal that you've eaten enough and the meal can end. It's controlled by stomach stretch, gut hormones (GLP-1, PYY, CCK, amylin), and central brain signals (especially in the hypothalamus). Modern weight-loss peptides — GLP-1s, amylin analogs — work largely by strengthening satiety so people naturally eat less without willpower battles.
- #Scar Tissue tissue
- Scar tissue is the result of repair via fibrosis: dense, mostly type-I collagen replacing the original tissue architecture. It restores structural continuity but typically lacks the function of the original (no contractile activity in cardiac scar, no melanocytes in skin scar, reduced strength in tendon scar). Anti-fibrotic and pro-regenerative interventions aim to bias healing toward true regeneration rather than scarring. TB-500, BPC-157, and GHK-Cu have been studied for their ability to improve the quality of healed tissue in preclinical models.
- #Secondary Endpoint methodology
- Secondary endpoints are additional outcomes measured in a trial that support but don't determine its success. They might include sub-population effects, mechanism-related lab values, or quality-of-life measures. Unless prespecified for hierarchical testing, positive secondary endpoints alone aren't enough for label claims, but they help interpret results and plan future studies.
- #Secretagogue endocrine
- A secretagogue is a compound that stimulates the release of a hormone from its natural source. Growth hormone secretagogues (Ipamorelin, GHRP-2, GHRP-6) bind the ghrelin receptor (GHSR-1a) on pituitary cells to trigger GH release. This approach preserves the body's natural pulsatile rhythm and feedback regulation better than direct hormone replacement.
- #Senescence cell-bio
- Cellular senescence is a state in which a cell permanently stops dividing but stays alive, often secreting inflammatory chemicals (the 'SASP' — senescence-associated secretory phenotype). A few senescent cells help with wound healing, but they accumulate with age and drive chronic inflammation, fibrosis, and frailty. 'Senolytic' drugs and peptides that clear these cells are an active longevity research area.
- #Serotonin neural
- Serotonin (5-HT) is a neurotransmitter that regulates mood, sleep, appetite, and many other functions — about 90% of it is actually made in the gut. SSRIs treat depression by raising serotonin signaling. Serotonin pathways also influence weight (the melanocortin pathway PT-141 acts on involves serotonergic and dopaminergic inputs). Imbalances are linked to depression, anxiety, OCD, and IBS.
- #Sirtuins molecular
- Sirtuins (SIRT1 through SIRT7) are NAD+-dependent enzymes that regulate gene expression, DNA repair, and metabolic stress responses. SIRT1 in particular is linked to caloric restriction's lifespan benefits. They strip acetyl groups off proteins, changing how those proteins work. Boosting NAD+ levels (with precursors like NMN or NR) is one strategy to keep sirtuins active as we age.
- #Skin Elasticity tissue
- Skin elasticity describes the recoil capacity of skin after deformation, measured clinically with devices like the Cutometer. It depends on the density and quality of dermal collagen and elastin fibers, hydration of the extracellular matrix, and the absence of glycation cross-links. Elasticity declines with chronological aging and accelerates with sun damage (photoaging), smoking, and high blood sugar. Peptide therapies for skin — GHK-Cu, Argireline, palmitoyl pentapeptide — target elasticity by stimulating fibroblasts and reducing matrix breakdown.
- #Sleep Quality neural
- Sleep quality refers to the architectural and subjective dimensions of sleep — proportion of deep (slow-wave) sleep, REM sleep, fragmentation, latency to fall asleep, and morning refreshment. Quality declines with age, alcohol, stress, sleep apnea, and irregular schedules. Deep sleep is when most growth hormone is released, making it a leverage point for peptide protocols. DSIP is the canonical 'sleep peptide' but has limited modern clinical data; growth-hormone-axis peptides dosed at bedtime may also affect sleep architecture.
- #Soft Tissue tissue
- Soft tissue is a clinical umbrella term for non-osseous tissues, including skeletal muscle, tendons, ligaments, fascia, fat, nerves, blood vessels, and the cartilage surfaces of joints. Soft-tissue injuries — sprains, strains, tears, tendinopathies, and overuse injuries — are the most common reasons users seek out healing peptides. BPC-157 and TB-500 are the most-discussed in this context because preclinical research suggests they accelerate ligament, tendon, and muscle repair.
- #Stem Cell cell-bio
- Stem cells have two unique abilities: they can self-renew (make more stem cells) and they can differentiate into specialized cells like muscle, nerve, or blood. Adult stem cells live in most tissues — bone marrow, muscle, gut, brain — where they replace cells lost to injury or wear. Many peptides are researched for their ability to mobilize or activate stem cells, including BPC-157 (muscle and tendon), GHK-Cu (skin and hair), and TB-500 (heart and blood vessels).
- #Stress Response neural
- The stress response is the integrated physiological reaction to perceived threat or challenge, mediated by the sympathetic nervous system (rapid: adrenaline release, increased heart rate, raised glucose) and the HPA axis (slower: cortisol release, immune modulation, behavioral effects). Acute stress responses are adaptive; chronic activation drives metabolic, cardiovascular, and mental health disease. Selank, DSIP, and certain neuropeptides are studied for blunting maladaptive chronic stress responses without disabling acute protective ones.
- #Stroke cardiovascular-disease-mention
- Stroke is acute brain injury from disrupted blood flow — either ischemic (clot blocking a vessel, ~85%) or hemorrhagic (vessel rupture, ~15%). Symptoms include sudden weakness, speech problems, facial drooping, vision loss, severe headache. Treatment within hours (clot-busting drugs or mechanical clot removal) can dramatically reduce damage. Neuroprotective and recovery-promoting peptides are studied for stroke aftermath.
- #Subcutaneous pharmacology
- Subcutaneous (SC or SubQ) injection delivers a drug into the fatty layer just beneath the skin. It absorbs more slowly than IV or intramuscular routes, giving a steadier blood level. Most peptide therapies are subcutaneous — insulin, GLP-1s, growth hormone, BPC-157, and others — because the route is well-tolerated, doesn't require a clinician, and works well with peptide pharmacokinetics.
- #Subcutaneous Injection pharma
- A subcutaneous injection delivers a drug or peptide into the fatty layer just beneath the skin rather than into a vein or muscle. The site is typically the abdomen, outer thigh, or back of the upper arm, and an insulin-style syringe with a short 4–8 mm needle is used. Absorption is slower and steadier than intravenous dosing, which makes this route well-suited for short-half-life peptides taken daily. Most peptide protocols Casey covers — BPC-157, Ipamorelin, Sermorelin, Tesamorelin, Semaglutide — use this route.
- #Synaptic Plasticity neural
- Synaptic plasticity is the change in strength of connections (synapses) between neurons in response to activity. Long-term potentiation (LTP) strengthens connections used during learning; long-term depression weakens unused ones. BDNF, NMDA receptors, and many neurotransmitters tune plasticity. Peptides like Semax and Cerebrolysin are studied for enhancing it, especially after injury or in aging.
- #Synthetic Peptide molecular
- A synthetic peptide is one manufactured by chemical synthesis rather than extracted from a biological source. Solid-phase peptide synthesis (SPPS), developed by Bruce Merrifield, is the standard method: amino acids are added one at a time onto a growing chain anchored to a resin. Synthetic peptides can be identical to natural sequences (Sermorelin) or designed analogs with improved properties (Semaglutide, Tirzepatide). Most research peptides sold to consumers — BPC-157, TB-500, Ipamorelin, GHK-Cu — are synthetic.
- #Systematic Review methodology
- A systematic review uses prespecified methods to find, evaluate, and synthesize all relevant studies on a question. Often paired with a meta-analysis. The systematic part — explicit search terms, inclusion criteria, quality assessment — distinguishes it from informal 'narrative reviews.' Cochrane reviews are the most rigorous examples.
T
- #T-Cell immune
- T-cells (T lymphocytes) are immune cells that mature in the thymus and recognize specific antigens. Subtypes include CD8 cytotoxic T-cells (kill infected/cancer cells), CD4 helper T-cells (coordinate other immune cells), and regulatory T-cells (prevent autoimmunity). T-cell modulation is central to cancer immunotherapy, autoimmune disease, and immune-supportive peptide research.
- #Telomere cell-bio
- Telomeres are repetitive DNA sequences that cap and protect chromosome ends. Every cell division shaves a bit off; when telomeres get critically short, cells stop dividing and enter senescence. Telomere length is a (rough) biomarker of biological age. Lifestyle factors (exercise, sleep, stress reduction) protect telomeres; peptides like Epitalon are studied for telomere preservation, though human evidence remains limited.
- #Tendon musculoskeletal
- Tendons are dense bands of collagen-rich connective tissue that transmit muscle force to bone. They have low blood supply, which is why tendon injuries (Achilles, patellar, rotator cuff) heal slowly and often incompletely. Peptides like BPC-157 and TB-500 are widely studied (largely in animals) for accelerating tendon repair through angiogenesis, fibroblast support, and matrix remodeling.
- #Tendon Healing regenerative
- Tendon healing proceeds through inflammation (days 1–7), proliferation with fibroblast collagen deposition (days 5–21), and remodeling (weeks 4 onward, sometimes for over a year). Because tendons have relatively poor vascular supply, healing is slower and produces tissue with mechanical properties inferior to the original. Improving the speed and quality of tendon healing is one of the most-asked-about applications of BPC-157 and TB-500; preclinical evidence is encouraging, though large human trials remain limited.
- #Testosterone endocrine
- Testosterone is a steroid hormone produced mainly in the testes (in men) and in smaller amounts in ovaries and adrenals (in women). It supports muscle mass, bone density, red blood cell production, libido, mood, and energy. Levels decline gradually with age. Therapy replaces testosterone directly; some peptides (Kisspeptin-10, Enclomiphene) work upstream to encourage the body to make more.
- #Third-Party Testing research
- Third-party testing is product verification performed by an independent laboratory not affiliated with the seller, producing a certificate of analysis (COA) that documents identity, purity, and absence of contaminants. For research peptides, common COA tests include HPLC for purity, mass spectrometry for identity confirmation, and endotoxin testing for injectability. Casey's vendor reviews weight COA practices heavily because the unregulated peptide market includes products that are underdosed, mislabeled, or contaminated. Reputable vendors publish lot-specific COAs on every batch.
- #Thymosin Alpha-1 immune
- Thymosin Alpha-1 (Tα1) is a 28-amino-acid peptide naturally produced by the thymus that activates dendritic cells and T-cells, supporting balanced immune function. As the drug Zadaxin it is approved in over 30 countries for chronic hepatitis B, hepatitis C, and as an immune adjuvant for cancer therapy. Research peptide use targets immune resilience, chronic infection recovery, and post-viral fatigue. Side-effect profiles in clinical trials have been favorable, with the main caution being autoimmune conditions where increased immune activity is undesirable.
- #Thymosin Beta-4 (TB-500) regenerative
- Thymosin Beta-4 (Tβ4) is a 43-amino-acid peptide originally isolated from the thymus but expressed in virtually every cell. Its primary biochemical role is sequestering G-actin, regulating cell shape and migration. Therapeutically it has been studied for corneal wound healing, cardiac repair after infarction, neurological recovery, and tendon/ligament healing. TB-500 is a research-peptide fragment that recapitulates much of full-length Tβ4 activity. The cardiac regeneration work overlaps directly with the epicardial progenitor cell biology in Phase 1 of the glossary.
- #Thymus immune
- The thymus is a primary lymphoid organ located in the upper chest where immature T-cell precursors migrate from bone marrow to undergo selection and differentiation into functional T-cells. The gland is largest in childhood and progressively shrinks (involutes) after puberty, contributing to age-related immune decline. Thymic peptides — Thymosin Alpha-1, Thymosin Beta-4, and Thymulin — are derived from or named after thymus tissue and are studied for their immune-modulating effects. Casey's articles on thymosin peptides start with thymus biology because most consumers haven't encountered the gland by name.
- #Thyroid endocrine
- The thyroid gland produces T3 and T4 hormones that regulate metabolic rate, body temperature, heart rate, weight, mood, and energy. Hypothyroidism (low function) causes fatigue, weight gain, and cold intolerance; hyperthyroidism (high function) causes weight loss, anxiety, and rapid heart rate. Hashimoto's (autoimmune) is the most common cause of hypothyroidism in developed countries. Peptide and other therapies often check thyroid status as a baseline.
- #Tissue Regeneration regenerative
- Tissue regeneration is the replacement of damaged or lost tissue with new functional tissue rather than non-functional scar, requiring a coordinated sequence of inflammation resolution, progenitor cell activation, angiogenesis, and extracellular matrix remodeling. Most adult human tissues heal with a mix of regeneration and fibrosis; the balance depends on tissue type, injury severity, and signaling environment. Several peptides are studied for tipping the balance toward regeneration: TB-500 in heart and tendon, BPC-157 in gut and musculoskeletal tissues, GHK-Cu in skin.
- #Tissue Remodeling regenerative
- Tissue remodeling is the final phase of wound healing in which the immature granulation tissue and randomly arranged type III collagen of the initial repair are gradually replaced by aligned, mature type I collagen. The process takes weeks to months and involves matrix metalloproteinases (MMPs) breaking down disorganized collagen while fibroblasts deposit new, properly oriented fibers. Quality of remodeling determines whether a healed tendon, ligament, or skin is strong and functional. BPC-157 and TB-500 are studied for their effects on this phase specifically.
- #Transcription Factor molecular
- Transcription factors are proteins that bind specific DNA sequences and either activate or block the reading of nearby genes. They're how cells respond to signals — hormone hits a receptor, the receptor activates a transcription factor, the factor changes which genes are on, and the cell's behavior shifts. Examples include NF-κB (inflammation), Nrf2 (antioxidants), and FoxO (longevity). Peptides ultimately produce most of their effects by changing which transcription factors are active.
- #Triglyceride
- Triglycerides are the storage form of fat in adipose tissue and the main lipid you eat. After meals they rise in blood, then get cleared into fat cells and muscle for storage or fuel. High fasting triglycerides indicate metabolic dysfunction and increase risk of pancreatitis and cardiovascular events. Metabolic peptides (GLP-1s, Tirzepatide, fibrates) lower triglycerides significantly.
- #Tumor Necrosis Factor immune
- Tumor necrosis factor (TNF-α) is a cytokine produced mainly by activated macrophages. It drives inflammation, fever, and acute-phase responses. Chronically elevated TNF causes autoimmune damage in rheumatoid arthritis, IBD, psoriasis, and ankylosing spondylitis. TNF blockers (adalimumab, infliximab) are blockbuster biologics. Many wound-healing peptides reduce excess TNF locally.
- #Type 1 Diabetes
- Type 1 diabetes (T1D) is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. It usually appears in childhood or young adulthood (though adult-onset 'LADA' is increasingly recognized). Patients require lifelong insulin therapy. Closed-loop insulin pumps and CGMs have dramatically improved control. Cell therapies and disease-modifying immunotherapies are active research areas.
- #Type 2 Diabetes
- Type 2 diabetes (T2D) accounts for about 90–95% of diabetes cases. It develops when insulin resistance outpaces the pancreas's ability to compensate, causing chronic high blood sugar. Risk factors include excess weight, sedentary lifestyle, family history, and age. Long-term high glucose damages eyes, kidneys, nerves, and blood vessels. GLP-1 receptor agonists are now the most-used class beyond metformin for both glycemic and weight benefits.
U
- #Ulcer musculoskeletal
- An ulcer is a break in a body surface — typically skin or mucous membrane — that doesn't heal normally. Stomach ulcers come from acid plus H. pylori or NSAIDs. Diabetic foot ulcers come from poor circulation and nerve damage. Pressure ulcers come from prolonged pressure on skin. BPC-157 ('body protective compound') was originally isolated from gastric juice and is most studied for healing GI ulcers; topical peptides like GHK-Cu are studied for skin ulcers.
- #Ulcerative Colitis immune-disease-mention
- Ulcerative colitis (UC) is an inflammatory bowel disease causing continuous inflammation limited to the colon's inner lining. Symptoms include bloody diarrhea, urgency, abdominal cramping, and weight loss. Severity ranges from proctitis to pancolitis. Treatments include 5-ASA drugs, immunomodulators, and biologics. Peptides like KPV are studied for their ability to calm GI inflammation, mainly in preclinical and small clinical studies.
V
- #Vasodilation cardiovascular
- Vasodilation is the widening of blood vessels, mainly through relaxation of the smooth muscle in their walls. It's triggered by signals like nitric oxide. Vasodilation lowers blood pressure, increases blood flow to tissues, and aids erection (a key mechanism behind PT-141 for sexual function). Many cardiovascular drugs and some peptides act through this mechanism.
- #VEGF molecular
- VEGF (vascular endothelial growth factor) is the master signal for angiogenesis — the formation of new blood vessels. It's released by tissues that need more blood supply (injured, growing, or oxygen-starved) and binds to receptors on endothelial cells to start vessel sprouting. Peptides like BPC-157 raise VEGF expression locally, which is one mechanism behind their wound-healing effects. Tumors hijack VEGF to feed themselves, which is why some cancer drugs block it.
- #Vial Strength pharma
- Vial strength is the amount of peptide loaded into each lyophilized vial, typically labeled in milligrams (e.g., 'BPC-157 5 mg vial'). To calculate a dose, the user divides total micrograms in the vial by the volume of bacteriostatic water added, then converts to syringe units. Higher vial strengths mean smaller injection volumes per dose, which can be more comfortable but less forgiving of dosing math errors. Casey's dosage calculators handle this conversion automatically because manual math is where most consumers make mistakes.
- #Visceral Fat
- Visceral fat is the fat that wraps around abdominal organs (liver, intestines, pancreas). Unlike subcutaneous fat, visceral fat secretes pro-inflammatory signals and free fatty acids straight into the liver, driving insulin resistance, fatty liver, and cardiovascular risk. Waist circumference is a rough proxy; CT or MRI gives precise measurement. Many peptide therapies preferentially reduce visceral over subcutaneous fat.
W
- #Waist Circumference
- Waist circumference is measured at the level of the iliac crest or navel. Higher numbers correlate with more visceral fat and metabolic risk independent of BMI. General cutoffs: over 40 inches (102 cm) in men or 35 inches (88 cm) in women signal elevated risk. It's a routine secondary endpoint in metabolic peptide trials.
- #Water Retention pharma
- Water retention (fluid retention, edema) is the accumulation of extracellular fluid, often noticed as puffiness in the hands, feet, or face or as a temporary scale-weight increase. With growth-hormone-releasing peptides (Tesamorelin, CJC-1295, Sermorelin), mild water retention is common in the first few weeks as IGF-1 rises and the body shifts sodium handling; it usually subsides as dosing stabilizes. With GLP-1 agonists, water retention is less typical but can occur. Persistent severe edema warrants medical evaluation.
- #Wound Healing musculoskeletal
- Wound healing unfolds in four overlapping stages: hemostasis (clotting), inflammation (cleanup), proliferation (new tissue), and remodeling (scar maturation). Each stage requires the right cells, signals, and timing. Many peptides — BPC-157 (gut, tendon), GHK-Cu (skin), TB-500 (broad tissues), KPV (skin) — are studied for accelerating one or more stages of wound healing.
- #Wrinkle skin
- Wrinkles result from a combination of intrinsic aging (gradual collagen and elastin loss), photoaging (UV-driven matrix breakdown), repetitive muscle pull, and reduced hydration. Topical peptides like Matrixyl and GHK-Cu are studied for their ability to stimulate collagen and improve fine lines. Botulinum toxin works on dynamic wrinkles by relaxing the underlying muscle.
No terms match your search. Try a different word.